
--- Page 1 ---
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION MEMORANDUM
A. 510(k) Number: K142677
B. Purpose for Submission:
To add the following additional organism identification claims to the already cleared device
K130831.
Bacteria
Acinetobacter haemolyticus Clostridium perfringens
Acinetobacter johnsonii Corynebacterium amycolatum
Acinetobacter junii Corynebacterium aurimucosum group
Actinomyces meyeri Corynebacterium bovis
Actinomyces neuii Corynebacterium diphtheriae
Actinomyces odontolyticus Corynebacterium glucuronolyticum
Actinomyces oris Corynebacterium jeikeium
Aerococcus urinae Corynebacterium kroppenstedtii
Aerococcus viridans Corynebacterium macginleyi
Aeromonas salmonicida Corynebacterium minutissimum
Anaerococcus vaginalis Corynebacterium propinquum
Bacteroides fragilis Corynebacterium pseudodiphtheriticum
Bacteroides ovatus group Corynebacterium riegelii
Bacteroides thetaiotaomicron group Corynebacterium striatum group
Bacteroides uniformis Corynebacterium tuberculostearicum
Bacteroides vulgatus group Corynebacterium ulcerans
Bordetella group[3] Corynebacterium urealyticum
Bordetella hinzii Corynebacterium xerosis
Brevibacterium casei Cronobacter sakazakii group
Brevundimonas diminuta group Cupriavidus pauculus group
Campylobacter coli Delftia acidovorans group
Campylobacter jejuni Dermacoccus nishinomiyaensis
Campylobacter ureolyticus Edwardsiella tarda
Capnocytophaga ochracea Elizabethkingia meningoseptica group
Capnocytophaga sputigena Enterobacter amnigenus
Chryseobacterium gleum Enterococcus avium group
Chryseobacterium indologenes Enterococcus casseliflavus
Clostridium difficile Enterococcus faecalis
1

[Table 1 on page 1]
Bacteria	
Acinetobacter haemolyticus
Acinetobacter johnsonii
Acinetobacter junii
Actinomyces meyeri
Actinomyces neuii
Actinomyces odontolyticus
Actinomyces oris
Aerococcus urinae
Aerococcus viridans
Aeromonas salmonicida
Anaerococcus vaginalis
Bacteroides fragilis
Bacteroides ovatus group
Bacteroides thetaiotaomicron group
Bacteroides uniformis
Bacteroides vulgatus group
Bordetella group[3]
Bordetella hinzii
Brevibacterium casei
Brevundimonas diminuta group
Campylobacter coli
Campylobacter jejuni
Campylobacter ureolyticus
Capnocytophaga ochracea
Capnocytophaga sputigena
Chryseobacterium gleum
Chryseobacterium indologenes
Clostridium difficile	Clostridium perfringens
Corynebacterium amycolatum
Corynebacterium aurimucosum group
Corynebacterium bovis
Corynebacterium diphtheriae
Corynebacterium glucuronolyticum
Corynebacterium jeikeium
Corynebacterium kroppenstedtii
Corynebacterium macginleyi
Corynebacterium minutissimum
Corynebacterium propinquum
Corynebacterium pseudodiphtheriticum
Corynebacterium riegelii
Corynebacterium striatum group
Corynebacterium tuberculostearicum
Corynebacterium ulcerans
Corynebacterium urealyticum
Corynebacterium xerosis
Cronobacter sakazakii group
Cupriavidus pauculus group
Delftia acidovorans group
Dermacoccus nishinomiyaensis
Edwardsiella tarda
Elizabethkingia meningoseptica group
Enterobacter amnigenus
Enterococcus avium group
Enterococcus casseliflavus
Enterococcus faecalis

--- Page 2 ---
Bacteria
Enterococcus faecium Rothia aeria
Enterococcus gallinarum Rothia dentocariosa
Enterococcus hirae Rothia mucilaginosa
Finegoldia magna Serratia plymuthica
Fusobacterium canifelinum Serratia rubidaea
Fusobacterium necrophorum Staphylococcus aureus
Fusobacterium nucleatum Staphylococcus auricularis
Gardnerella vaginalis Staphylococcus capitis
Gemella haemolysans Staphylococcus caprae
Gemella sanguinis Staphylococcus carnosus
Granulicatella adiacens Staphylococcus cohnii
Haemophilus haemolyticus Staphylococcus epidermidis
Haemophilus influenzae Staphylococcus equorum
Haemophilus parahaemolyticus group Staphylococcus felis
Kingella kingae Staphylococcus haemolyticus
Kocuria kristinae Staphylococcus hominis
Kytococcus sedentarius Staphylococcus lugdunensis
Lactococcus garvieae Staphylococcus pasteuri
Lactococcus lactis Staphylococcus pettenkoferi
Leuconostoc mesenteroides Staphylococcus pseudintermedius
Macrococcus caseolyticus Staphylococcus saccharolyticus
Micrococcus luteus Staphylococcus saprophyticus
Moraxella sg Moraxella nonliquefaciens Staphylococcus schleiferi
Myroides odoratimimus Staphylococcus simulans
Myroides odoratus Staphylococcus vitulinus
Oligella ureolytica Staphylococcus warneri
Oligella urethralis Streptococcus agalactiae
Parabacteroides distasonis Streptococcus anginosus
Pediococcus pentosaceus Streptococcus constellatus
Peptoniphilus harei group Streptococcus dysgalactiae
Peptostreptococcus anaerobius Streptococcus gallolyticus
Plesiomonas shigelloides Streptococcus gordonii
Porphyromonas gingivalis Streptococcus intermedius
Prevotella bivia Streptococcus lutetiensis
Prevotella buccae Streptococcus mitis/oralis group
Prevotella denticola Streptococcus mutans
Prevotella intermedia Streptococcus pneumoniae
Prevotella melaninogenica Streptococcus pyogenes
Propionibacterium acnes Streptococcus salivarius
Pseudomonas oryzihabitans Sutterella wadsworthensis
Pseudomonas stutzeri Vibrio parahaemolyticus
Rhizobium radiobacter Vibrio vulnificus
2

[Table 1 on page 2]
Bacteria	
Enterococcus faecium
Enterococcus gallinarum
Enterococcus hirae
Finegoldia magna
Fusobacterium canifelinum
Fusobacterium necrophorum
Fusobacterium nucleatum
Gardnerella vaginalis
Gemella haemolysans
Gemella sanguinis
Granulicatella adiacens
Haemophilus haemolyticus
Haemophilus influenzae
Haemophilus parahaemolyticus group
Kingella kingae
Kocuria kristinae
Kytococcus sedentarius
Lactococcus garvieae
Lactococcus lactis
Leuconostoc mesenteroides
Macrococcus caseolyticus
Micrococcus luteus
Moraxella sg Moraxella nonliquefaciens
Myroides odoratimimus
Myroides odoratus
Oligella ureolytica
Oligella urethralis
Parabacteroides distasonis
Pediococcus pentosaceus
Peptoniphilus harei group
Peptostreptococcus anaerobius
Plesiomonas shigelloides
Porphyromonas gingivalis
Prevotella bivia
Prevotella buccae
Prevotella denticola
Prevotella intermedia
Prevotella melaninogenica
Propionibacterium acnes
Pseudomonas oryzihabitans
Pseudomonas stutzeri
Rhizobium radiobacter	Rothia aeria
Rothia dentocariosa
Rothia mucilaginosa
Serratia plymuthica
Serratia rubidaea
Staphylococcus aureus
Staphylococcus auricularis
Staphylococcus capitis
Staphylococcus caprae
Staphylococcus carnosus
Staphylococcus cohnii
Staphylococcus epidermidis
Staphylococcus equorum
Staphylococcus felis
Staphylococcus haemolyticus
Staphylococcus hominis
Staphylococcus lugdunensis
Staphylococcus pasteuri
Staphylococcus pettenkoferi
Staphylococcus pseudintermedius
Staphylococcus saccharolyticus
Staphylococcus saprophyticus
Staphylococcus schleiferi
Staphylococcus simulans
Staphylococcus vitulinus
Staphylococcus warneri
Streptococcus agalactiae
Streptococcus anginosus
Streptococcus constellatus
Streptococcus dysgalactiae
Streptococcus gallolyticus
Streptococcus gordonii
Streptococcus intermedius
Streptococcus lutetiensis
Streptococcus mitis/oralis group
Streptococcus mutans
Streptococcus pneumoniae
Streptococcus pyogenes
Streptococcus salivarius
Sutterella wadsworthensis
Vibrio parahaemolyticus
Vibrio vulnificus

--- Page 3 ---
YEASTS
Candida albicans Candida orthopsilosis
Candida boidinii Candida parapsilosis
Candida dubliniensis Candida pararugosa
Candida duobushaemulonii Candida pelliculosa
Candida famata Candida tropicalis
Candida glabrata Candida valida
Candida guilliermondii Cryptococcus gattii
Candida haemulonis Cryptococcus neoformans var grubii
Candida inconspicua Cryptococcus neoformans var neoformans
Candida kefyr Geotrichum candidum
Candida krusei Geotrichum capitatum
Candida lambica Kloeckera apiculata
Candida lipolytica Pichia ohmeri
Candida lusitaniae Saccharomyces cerevisiae
Candida metapsilosis Trichosporon asahii
Candida norvegensis
C. Measurand: See Intended Use
D. Type of Test:
The MALDI Biotyper CA System is a qualitative in vitro diagnostic device intended for the
identification of microorganisms cultured from human specimens. The device is comprised
of an ionization source, a mass analyzer and a spectral database. The device is indicated for
use in conjunction with other clinical and laboratory findings to aid in the diagnosis of
bacterial and fungal infections.
E. Applicant:
Bruker Daltonics, Inc.
F. Proprietary and Established Names:
Trade Name: MALDI Biotyper CA System
Common Name: MBT-CA System
G. Regulatory Information:
1. Regulation section: 21 CFR 866.3361
2. Classification: Class II (special controls)
3

[Table 1 on page 3]
YEASTS	
Candida albicans
Candida boidinii
Candida dubliniensis
Candida duobushaemulonii
Candida famata
Candida glabrata
Candida guilliermondii
Candida haemulonis
Candida inconspicua
Candida kefyr
Candida krusei
Candida lambica
Candida lipolytica
Candida lusitaniae
Candida metapsilosis
Candida norvegensis	Candida orthopsilosis
Candida parapsilosis
Candida pararugosa
Candida pelliculosa
Candida tropicalis
Candida valida
Cryptococcus gattii
Cryptococcus neoformans var grubii
Cryptococcus neoformans var neoformans
Geotrichum candidum
Geotrichum capitatum
Kloeckera apiculata
Pichia ohmeri
Saccharomyces cerevisiae
Trichosporon asahii

--- Page 4 ---
3. Product code: PEX
4. Panel: Microbiology (83)
H. Intended Use:
1. Intended use(s):
The Bruker Daltonics, Inc. MALDI Biotyper CA System is a mass spectrometer system
using matrix-assisted laser desorption/ionization – time-of-flight (MALDI-TOF) for the
identification of microorganisms cultured from human specimens.
The MALDI Biotyper CA System is a qualitative in vitro diagnostic device indicated for
use in conjunction with other clinical and laboratory findings to aid in the diagnosis of
bacterial and yeast infections.
The following organisms are claimed:
Bacteria
Achromobacter xylosoxidans Burkholderia gladioli
Acinetobacter haemolyticus Burkholderia multivorans
Acinetobacter johnsonii Burkholderia cepacia complex [13]
Acinetobacter junii Campylobacter coli
Acinetobacter lwoffii Campylobacter jejuni
Acinetobacter radioresistens Campylobacter ureolyticus
Acinetobacter ursingii Capnocytophaga ochracea
Acinetobacter baumannii complex [4] Capnocytophaga sputigena
Actinomyces meyeri Chryseobacterium gleum
Actinomyces neuii Chryseobacterium indologenes
Actinomyces odontolyticus Citrobacter amalonaticus complex
Actinomyces oris Citrobacter koseri
Aerococcus urinae Citrobacter freundii complex
Aerococcus viridans Clostridium difficile
Aeromonas salmonicida Clostridium perfringens
Aeromonas sp[7] Corynebacterium amycolatum
Alcaligenes faecalis Corynebacterium aurimucosum group
Anaerococcus vaginalis Corynebacterium bovis
Bacteroides fragilis Corynebacterium diphtheriae
Bacteroides ovatus group Corynebacterium glucuronolyticum
Bacteroides uniformis Corynebacterium jeikeium
Bacteroides thetaiotaomicron group Corynebacterium kroppenstedtii
Bacteroides vulgatus group Corynebacterium macginleyi
Bordetella group[3] Corynebacterium minutissimum
Bordetella hinzii Corynebacterium propinquum
Brevibacterium casei Corynebacterium pseudodiphtheriticum
Brevundimonas diminuta group Corynebacterium riegelii
4

[Table 1 on page 4]
Bacteria	
Achromobacter xylosoxidans
Acinetobacter haemolyticus
Acinetobacter johnsonii
Acinetobacter junii
Acinetobacter lwoffii
Acinetobacter radioresistens
Acinetobacter ursingii
Acinetobacter baumannii complex [4]
Actinomyces meyeri
Actinomyces neuii
Actinomyces odontolyticus
Actinomyces oris
Aerococcus urinae
Aerococcus viridans
Aeromonas salmonicida
Aeromonas sp[7]
Alcaligenes faecalis
Anaerococcus vaginalis
Bacteroides fragilis
Bacteroides ovatus group
Bacteroides uniformis
Bacteroides thetaiotaomicron group
Bacteroides vulgatus group
Bordetella group[3]
Bordetella hinzii
Brevibacterium casei
Brevundimonas diminuta group	Burkholderia gladioli
Burkholderia multivorans
Burkholderia cepacia complex [13]
Campylobacter coli
Campylobacter jejuni
Campylobacter ureolyticus
Capnocytophaga ochracea
Capnocytophaga sputigena
Chryseobacterium gleum
Chryseobacterium indologenes
Citrobacter amalonaticus complex
Citrobacter koseri
Citrobacter freundii complex
Clostridium difficile
Clostridium perfringens
Corynebacterium amycolatum
Corynebacterium aurimucosum group
Corynebacterium bovis
Corynebacterium diphtheriae
Corynebacterium glucuronolyticum
Corynebacterium jeikeium
Corynebacterium kroppenstedtii
Corynebacterium macginleyi
Corynebacterium minutissimum
Corynebacterium propinquum
Corynebacterium pseudodiphtheriticum
Corynebacterium riegelii

--- Page 5 ---
Bacteria
Corynebacterium tuberculostearicum Macrococcus caseolyticus
Corynebacterium ulcerans Micrococcus luteus
Corynebacterium urealyticum Moraxella sg Branhamella catarrhalis
Corynebacterium xerosis Moraxella sg Moraxella nonliquefaciens
Corynebacterium striatum group Moraxella sg Moraxella osloensis
Cronobacter sakazakii group Morganella morganii
Cupriavidus pauculus group Myroides odoratimimus
Delftia acidovorans group Myroides odoratus
Dermacoccus nishinomiyaensis Oligella ureolytica
Edwardsiella tarda Oligella urethralis
Eikenella corrodens Pantoea agglomerans
Elizabethkingia meningoseptica group Parabacteroides distasonis
Enterobacter aerogenes Pasteurella multocida
Enterobacter amnigenus Pediococcus pentosaceus
Enterobacter cloacae complex Peptoniphilus harei group
Enterococcus casseliflavus Peptostreptococcus anaerobius
Enterococcus faecalis Plesiomonas shigelloides
Enterococcus faecium Porphyromonas gingivalis
Enterococcus gallinarum Prevotella bivia
Enterococcus hirae Prevotella buccae
Enterococcus avium group Prevotella denticola
Escherichia coli Prevotella intermedia
Finegoldia magna Prevotella melaninogenica
Fusobacterium canifelinum Propionibacterium acnes
Fusobacterium necrophorum Proteus mirabilis
Fusobacterium nucleatum Proteus vulgaris group
Gardnerella vaginalis Providencia rettgeri
Gemella haemolysans Providencia stuartii
Gemella sanguinis Pseudomonas aeruginosa
Granulicatella adiacens Pseudomonas fluorescens group
Haemophilus haemolyticus Pseudomonas oryzihabitans
Haemophilus influenzae Pseudomonas putida group
Haemophilus parainfluenzae Pseudomonas stutzeri
Haemophilus parahaemolyticus group Rhizobium radiobacter
Hafnia alvei Rothia aeria
Kingella kingae Rothia dentocariosa
Klebsiella pneumoniae Rothia mucilaginosa
Klebsiella oxytoca/ Raoultella ornithinolytica Salmonella sp
Kocuria kristinae Serratia liquefaciens
Kytococcus sedentarius Serratia marcescens
Lactococcus lactis Serratia plymuthica
Lactococcus garvieae Serratia rubidaea
Leuconostoc mesenteroides Staphylococcus aureus
5

[Table 1 on page 5]
Bacteria	
Corynebacterium tuberculostearicum
Corynebacterium ulcerans
Corynebacterium urealyticum
Corynebacterium xerosis
Corynebacterium striatum group
Cronobacter sakazakii group
Cupriavidus pauculus group
Delftia acidovorans group
Dermacoccus nishinomiyaensis
Edwardsiella tarda
Eikenella corrodens
Elizabethkingia meningoseptica group
Enterobacter aerogenes
Enterobacter amnigenus
Enterobacter cloacae complex
Enterococcus casseliflavus
Enterococcus faecalis
Enterococcus faecium
Enterococcus gallinarum
Enterococcus hirae
Enterococcus avium group
Escherichia coli
Finegoldia magna
Fusobacterium canifelinum
Fusobacterium necrophorum
Fusobacterium nucleatum
Gardnerella vaginalis
Gemella haemolysans
Gemella sanguinis
Granulicatella adiacens
Haemophilus haemolyticus
Haemophilus influenzae
Haemophilus parainfluenzae
Haemophilus parahaemolyticus group
Hafnia alvei
Kingella kingae
Klebsiella pneumoniae
Klebsiella oxytoca/ Raoultella ornithinolytica
Kocuria kristinae
Kytococcus sedentarius
Lactococcus lactis
Lactococcus garvieae
Leuconostoc mesenteroides	Macrococcus caseolyticus
Micrococcus luteus
Moraxella sg Branhamella catarrhalis
Moraxella sg Moraxella nonliquefaciens
Moraxella sg Moraxella osloensis
Morganella morganii
Myroides odoratimimus
Myroides odoratus
Oligella ureolytica
Oligella urethralis
Pantoea agglomerans
Parabacteroides distasonis
Pasteurella multocida
Pediococcus pentosaceus
Peptoniphilus harei group
Peptostreptococcus anaerobius
Plesiomonas shigelloides
Porphyromonas gingivalis
Prevotella bivia
Prevotella buccae
Prevotella denticola
Prevotella intermedia
Prevotella melaninogenica
Propionibacterium acnes
Proteus mirabilis
Proteus vulgaris group
Providencia rettgeri
Providencia stuartii
Pseudomonas aeruginosa
Pseudomonas fluorescens group
Pseudomonas oryzihabitans
Pseudomonas putida group
Pseudomonas stutzeri
Rhizobium radiobacter
Rothia aeria
Rothia dentocariosa
Rothia mucilaginosa
Salmonella sp
Serratia liquefaciens
Serratia marcescens
Serratia plymuthica
Serratia rubidaea
Staphylococcus aureus

--- Page 6 ---
Bacteria
Staphylococcus auricularis Stenotrophomonas maltophilia
Staphylococcus capitis Streptococcus agalactiae
Staphylococcus caprae Streptococcus anginosus
Staphylococcus carnosus Streptococcus constellatus
Staphylococcus cohnii Streptococcus dysgalactiae
Staphylococcus epidermidis Streptococcus gallolyticus
Staphylococcus equorum Streptococcus gordonii
Staphylococcus felis Streptococcus intermedius
Staphylococcus haemolyticus Streptococcus lutetiensis
Staphylococcus hominis Streptococcus mitis / oralis group
Staphylococcus lugdunensis Streptococcus mutans
Staphylococcus pasteuri Streptococcus pneumoniae
Staphylococcus pettenkoferi Streptococcus pyogenes
Staphylococcus pseudintermedius Streptococcus salivarius
Staphylococcus saccharolyticus Sutterella wadsworthensis
Staphylococcus saprophyticus Vibrio parahaemolyticus
Staphylococcus schleiferi Vibrio vulnificus
Staphylococcus simulans Yersinia enterocolitica
Staphylococcus vitulinus Yersinia pseudotuberculosis
Staphylococcus warneri
YEASTS
Candida albicans Candida orthopsilosis
Candida boidinii Candida parapsilosis
Candida dubliniensis Candida pararugosa
Candida duobushaemulonii Candida pelliculosa
Candida famata Candida tropicalis
Candida glabrata Candida valida
Candida guilliermondii Cryptococcus gattii
Candida haemulonis Cryptococcus neoformans var grubii
Candida inconspicua Cryptococcus neoformans var neoformans
Candida kefyr Geotrichum candidum
Candida krusei Geotrichum capitatum
Candida lambica Kloeckera apiculata
Candida lipolytica Pichia ohmeri
Candida lusitaniae Saccharomyces cerevisiae
Candida metapsilosis Trichosporon asahii
Candida norvegensis
2. Indication(s) for use: Same as intended use.
3. Special conditions for use statement(s):
The MALDI Biotyper CA System is for prescription use only in accordance with 21 CFR
801.109.
6

[Table 1 on page 6]
Bacteria	
Staphylococcus auricularis
Staphylococcus capitis
Staphylococcus caprae
Staphylococcus carnosus
Staphylococcus cohnii
Staphylococcus epidermidis
Staphylococcus equorum
Staphylococcus felis
Staphylococcus haemolyticus
Staphylococcus hominis
Staphylococcus lugdunensis
Staphylococcus pasteuri
Staphylococcus pettenkoferi
Staphylococcus pseudintermedius
Staphylococcus saccharolyticus
Staphylococcus saprophyticus
Staphylococcus schleiferi
Staphylococcus simulans
Staphylococcus vitulinus
Staphylococcus warneri	Stenotrophomonas maltophilia
Streptococcus agalactiae
Streptococcus anginosus
Streptococcus constellatus
Streptococcus dysgalactiae
Streptococcus gallolyticus
Streptococcus gordonii
Streptococcus intermedius
Streptococcus lutetiensis
Streptococcus mitis / oralis group
Streptococcus mutans
Streptococcus pneumoniae
Streptococcus pyogenes
Streptococcus salivarius
Sutterella wadsworthensis
Vibrio parahaemolyticus
Vibrio vulnificus
Yersinia enterocolitica
Yersinia pseudotuberculosis

[Table 2 on page 6]
YEASTS	
Candida albicans
Candida boidinii
Candida dubliniensis
Candida duobushaemulonii
Candida famata
Candida glabrata
Candida guilliermondii
Candida haemulonis
Candida inconspicua
Candida kefyr
Candida krusei
Candida lambica
Candida lipolytica
Candida lusitaniae
Candida metapsilosis
Candida norvegensis	Candida orthopsilosis
Candida parapsilosis
Candida pararugosa
Candida pelliculosa
Candida tropicalis
Candida valida
Cryptococcus gattii
Cryptococcus neoformans var grubii
Cryptococcus neoformans var neoformans
Geotrichum candidum
Geotrichum capitatum
Kloeckera apiculata
Pichia ohmeri
Saccharomyces cerevisiae
Trichosporon asahii

--- Page 7 ---
4. Special instrument requirements:
Mass Spectrometer: microflex LT/SH mass spectrometer
Target Plates: US IVD 48 Spot Target
Reagents:
• US IVD Bacterial Test Standard (BTS)
• US IVD HCCA portioned (α-Cyano-4-hydroxycinnamic acid)
Database: MALDI Biotyper for Clinical Applications (MBT-CA)
Software:
• MBT-CA System Software Package:
MBT-CA System client software displaying the user interface
MBT-CA System Server
MBT-CA System DB Server
• flexControl Software Package
GTPS firmware
flexControl acquisition software
Honeywell (Hyperion 1300g) Barcode Reader (optional)
I. Device Description:
The MBT-CA System consists of the microflex LT/SH mass spectrometer, reference
library, kit reagents (US IVD HCCA, US IVD Bacterial Test Standard), US IVD 48 Spot
Target slides, and software. The MALDI Biotyper CA System with closed safety covers is a
Class 1 Laser product. With the safety cover opened it becomes a Class 4 Laser product. The
laser is a 337 nm fixed focus, nitrogen laser. The MALDI Biotyper CA System also
referred to as the MBT-CA System.
The reference library, MALDI Biotyper for Clinical Applications, includes type strains,
clinical strains and culture collection strains. The MALDI Biotyper CA System reference
library was established by analyzing the type strain from each claimed species combined
with 5 to 38 additional strains from the same species provided by clinical laboratories or
different commercial strain collections for a total of 1492 strains. Library mass spectra
used for matching contain up to 70 peaks. The MALDI Biotyper for Clinical Applications
is also referred to as the MBT-CA.
US IVD HCCA portioned (α-Cyano-4-hydroxycinnamic acid) is a solution that is used
when processing test organisms for identification on the MALDI Biotyper CA System. US
IVD HCCA is reconstituted in accordance with instructions provided using recommended
solvent. 1.0 μL of the matrix is added to the spot with the sample and allowed to dry.
US IVD Bacterial Test Standard (BTS) is an in-vitro-diagnostic product used for quality
7

--- Page 8 ---
control and validation of the microflex LT/SH mass spectrometers. US IVD BTS
contains a manufactured extract of Escherichia coli DH5 alpha that demonstrates a
characteristic peptide and protein profile mass spectrum, when tested on the MALDI
Biotyper CA System. US IVD BTS is spiked with two additional proteins that extend the
upper boundary of the mass range of the US IVD BTS. The overall mass range covered
by US IVD BTS is 3.6 to 17 kDa.
US IVD 48 Spot Target plates are reusable steel plates which have been developed for the
preparation and identification of test organisms using the MALDI Biotyper CA System. The
target allows for the identification of 48 test organisms. The target has five cross-joint
positions which should be used for US IVD BTS control. Target plate cleaning is
performed after each run.
MALDI Biotyper CA System client software displays a user-interface which guides the
user through the MALDI Biotyper CA System workflow. The MALDI Biotyper CA
System client also interfaces to the flexControl software for automated acquisition of
mass spectra on the microflex LT/SH instrument.
The MALDI Biotyper CA System server communicates with the MALDI Biotyper CA
System client and the MBT-DB server. It performs preprocessing on acquired spectra,
and matches peaks lists against the Main Spectrum (reference pattern, (MSP)) for
matching and calculates the score value (log (score)). The MBT-DB server stores all
information for the MALDI Biotyper CA System. The MBT-DB maintains spectra data
(creation information and mass/intensity lists), project data (results of defined and
executed runs), method data (parameter lists for spectra preprocessing and identification),
user management data, reference patterns and other peak lists plus additional
maintenance data.
GTPS firmware communicates with the flexControl PC software, controls and monitors
the vacuum, moves the sample carrier and performs the docking of the target plate,
controls and monitors high voltages in the ion source, generates trigger signals, and
monitors instrument status.
The flexControl acquisition software communicates with the MALDI Biotyper CA
System client, loads automatic run jobs, communicates with the GTPS firmware,
communicates with the laser in the microflex LT/SH instrument, sets the acquisition
parameters in the digitizer and reads the acquired data from the digitizer, performs
automated data acquisition, evaluates acquired spectra, adjusts the laser power during
automatic data acquisition, performs a re-calibration of the time-of-flight to mass
transformation, stored acquired spectra on disk and performs source cleaning. The
flexControl software does not display a user interface.
The optional Honeywell (Hyperion 1300g) Barcode Reader USB cable is connected to
the MALDI Biotyper CA System computer. The barcode reader scans the unique ten-
digit target ID which appears in the Target ID box on the target plate. After the target ID
has been entered, the a new Run page opens and the ten-digit target ID appears as the
Plate Id and is appended to the Run name. Sample identifications are entered into the
computer corresponding to the target plate position for that run.
8

--- Page 9 ---
J. Substantial Equivalence Information:
1. Predicate device name(s):
Bruker Daltonics, Inc MBT-CA System, VITEK®MS
2. Predicate 510(k) number(s):
K124067, K130831
3. Comparison with predicate:
Similarities
Item Device Predicate Predicate
Bruker Daltonics,
Bruker Daltonics, Inc MBT-CA System VITEK MS (K124067) Inc MBT-CA
(K142677) System (K130831)
Product PEX PEX PEX
Code
The Bruker Daltonics, Inc. MALDI The VitekR MS is a mass See “Differences”
Intended Biotyper CA System is a mass spectrometer system using
Use spectrometer system using matrix- matrix-assisted laser
assisted laser desorption/ionization – desorption/ionization-time of
time-of-flight (MALDI-TOF) for the flight (MALDI-TOF) for the
identification of microorganisms identification of
cultured from human specimens. microorganisms cultured
from human specimen. The
The MALDI Biotyper CA System is a VITEK MS is a qualitative in
qualitative in vitro diagnostic device vitro diagnostic device
indicated for use in conjunction with indicated for use in
other clinical and laboratory findings to conjunction with other
aid in the diagnosis of bacterial and yeast clinical and laboratory
infections. findings to aid in the
diagnosis of bacterial and
yeast infections.
Isolated colony from any patient sample Isolated colony from any Isolated colony
Sample source. patient sample source. from any patient
type Acceptable media: sample source.
• Columbia blood agar with 5% sheep Acceptable media:
blood (Gram negative aerobic • Columbia blood agar with Acceptable media:
bacteria) 5% sheep blood • Columbia blood
• Trypticase soy agar with 5% sheep • Trypitcase soy agar with 5% agar with 5%
Blood (Gram negative aerobic sheep Blood sheep blood
bacteria, Gram-aerobic positive • Chocolate polyvitex agar • Trypticase soy
bacteria, yeasts) • Campylosel agar agar with 5%
• Chocolate agar (Gram-negative • MacConkey Agar sheep Blood
aerobic bacteria, Gram positive • Modified Sabouraud • Chocolate agar
aerobic bacteria) dextrose Agar • MacConkey Agar
• MacConkey Agar (Gram-negative • ChromID CPS
aerobic bacteria)
• Columbia CNA agar with 5% sheep
blood (Gram positive aerobic bacteria)
9

[Table 1 on page 9]
Similarities							
Item		Device		Predicate
VITEK MS (K124067)		Predicate	
						Bruker Daltonics,	
		Bruker Daltonics, Inc MBT-CA System				Inc MBT-CA	
		(K142677)				System (K130831)	
Product
Code	PEX			PEX	PEX		
Intended
Use	The Bruker Daltonics, Inc. MALDI
Biotyper CA System is a mass
spectrometer system using matrix-
assisted laser desorption/ionization –
time-of-flight (MALDI-TOF) for the
identification of microorganisms
cultured from human specimens.
The MALDI Biotyper CA System is a
qualitative in vitro diagnostic device
indicated for use in conjunction with
other clinical and laboratory findings to
aid in the diagnosis of bacterial and yeast
infections.			The VitekR MS is a mass
spectrometer system using
matrix-assisted laser
desorption/ionization-time of
flight (MALDI-TOF) for the
identification of
microorganisms cultured
from human specimen. The
VITEK MS is a qualitative in
vitro diagnostic device
indicated for use in
conjunction with other
clinical and laboratory
findings to aid in the
diagnosis of bacterial and
yeast infections.	See “Differences”		
Sample
type	Isolated colony from any patient sample
source.
Acceptable media:
• Columbia blood agar with 5% sheep
blood (Gram negative aerobic
bacteria)
• Trypticase soy agar with 5% sheep
Blood (Gram negative aerobic
bacteria, Gram-aerobic positive
bacteria, yeasts)
• Chocolate agar (Gram-negative
aerobic bacteria, Gram positive
aerobic bacteria)
• MacConkey Agar (Gram-negative
aerobic bacteria)
• Columbia CNA agar with 5% sheep
blood (Gram positive aerobic bacteria)			Isolated colony from any
patient sample source.
Acceptable media:
• Columbia blood agar with
5% sheep blood
• Trypitcase soy agar with 5%
sheep Blood
• Chocolate polyvitex agar
• Campylosel agar
• MacConkey Agar
• Modified Sabouraud
dextrose Agar
• ChromID CPS	Isolated colony
from any patient
sample source.
Acceptable media:
• Columbia blood
agar with 5%
sheep blood
• Trypticase soy
agar with 5%
sheep Blood
• Chocolate agar
• MacConkey Agar		

[Table 2 on page 9]
Predicate

VITEK MS (K124067)

--- Page 10 ---
Similarities
Item Device Predicate Predicate
Bruker Daltonics,
Bruker Daltonics, Inc MBT-CA System VITEK MS (K124067) Inc MBT-CA
(K142677) System (K130831)
• Brucella Agar with 5% horse blood
(Gram-negative anaerobic bacteria,
Gram-positive anaerobic bacteria)
• CDC anaerobe Agar with 5% sheep
blood (Gram-negative anaerobic
bacteria, Gram-positive
• anaerobic bacteria)
• CDC anaerobe 5% sheep blood Agar
with phenylethyl alcohol (Gram-
negative anaerobic bacteria, Gram-
positive anaerobic bacteria)
• CDC anaerobe laked sheep blood Agar
with kanamycin and vancomycin
(Gram-negative anaerobic bacteria)
• Bacteroides bile esculin Agar with
amikacin (Bacteroides species)
• Clostridium difficile Agar with 7%
sheep blood (Clostridium difficile)
• Sabouraud-Dextrose Agar (Yeasts)
• Brain Heart Infusion Agar (Yeasts)
• Campylobacter Agar with 5
Antimicrobics and 10% Sheep Blood
(Campylobacter species)
• Bordet Gengou Agar with 15% sheep
blood (Bordetella species)
Type of Automated Mass Spectrometry System Automated Mass Automated Mass
Test Spectrometry System Spectrometry
System
Matrix alpha-cyano-4-hydroxy-cinnamic acid alpha-cyano-4-hydroxy- alpha-cyano-4-
cinnamic acid hydroxy-cinnamic
acid
Method of Bacteria & Yeast: Direct testing Bacteria: Direct testing Bacteria: Direct
Testing testing
• If after initial analysis the log(score) is Yeast: Direct with VITEK
reported at <2.00, organisms may be MS-FA If after initial
processed using the analysis the log
• Extraction (Ext) procedure or extended (score) is reported
Direct Transfer (eDT, 70% aqueous at < 2.00,
formic acid). organisms are
• If eDT method still yields log(score) processed using the
<2.0, organism may be processed via extraction
Ext procedure. procedure.
Result Organism identification is reported with A single identification is Organism
Reporting high confidence if the log(score) is >2.0. displayed, with a confidence identification is
An organism identification is reported value from 60.0 to 99.9, when reported with high
with low confidence if the log(score) is one significant organism or confidence if the
between 1.70 and <2.00. organism group is retained. log(score) is >2.0.
“Low-discrimination” An organism
identifications are displayed identification is
when more than one but not reported with low
more than four significant confidence if the
organisms or organism log(score) is
10

[Table 1 on page 10]
Similarities							
Item		Device		Predicate
VITEK MS (K124067)		Predicate	
						Bruker Daltonics,	
		Bruker Daltonics, Inc MBT-CA System				Inc MBT-CA	
		(K142677)				System (K130831)	
	• Brucella Agar with 5% horse blood
(Gram-negative anaerobic bacteria,
Gram-positive anaerobic bacteria)
• CDC anaerobe Agar with 5% sheep
blood (Gram-negative anaerobic
bacteria, Gram-positive
• anaerobic bacteria)
• CDC anaerobe 5% sheep blood Agar
with phenylethyl alcohol (Gram-
negative anaerobic bacteria, Gram-
positive anaerobic bacteria)
• CDC anaerobe laked sheep blood Agar
with kanamycin and vancomycin
(Gram-negative anaerobic bacteria)
• Bacteroides bile esculin Agar with
amikacin (Bacteroides species)
• Clostridium difficile Agar with 7%
sheep blood (Clostridium difficile)
• Sabouraud-Dextrose Agar (Yeasts)
• Brain Heart Infusion Agar (Yeasts)
• Campylobacter Agar with 5
Antimicrobics and 10% Sheep Blood
(Campylobacter species)
• Bordet Gengou Agar with 15% sheep
blood (Bordetella species)						
Type of
Test	Automated Mass Spectrometry System			Automated Mass
Spectrometry System	Automated Mass
Spectrometry
System		
Matrix	alpha-cyano-4-hydroxy-cinnamic acid			alpha-cyano-4-hydroxy-
cinnamic acid	alpha-cyano-4-
hydroxy-cinnamic
acid		
Method of
Testing	Bacteria & Yeast: Direct testing
• If after initial analysis the log(score) is
reported at <2.00, organisms may be
processed using the
• Extraction (Ext) procedure or extended
Direct Transfer (eDT, 70% aqueous
formic acid).
• If eDT method still yields log(score)
<2.0, organism may be processed via
Ext procedure.			Bacteria: Direct testing
Yeast: Direct with VITEK
MS-FA	Bacteria: Direct
testing
If after initial
analysis the log
(score) is reported
at < 2.00,
organisms are
processed using the
extraction
procedure.		
Result
Reporting	Organism identification is reported with
high confidence if the log(score) is >2.0.
An organism identification is reported
with low confidence if the log(score) is
between 1.70 and <2.00.			A single identification is
displayed, with a confidence
value from 60.0 to 99.9, when
one significant organism or
organism group is retained.
“Low-discrimination”
identifications are displayed
when more than one but not
more than four significant
organisms or organism	Organism
identification is
reported with high
confidence if the
log(score) is >2.0.
An organism
identification is
reported with low
confidence if the
log(score) is		

[Table 2 on page 10]
Predicate

VITEK MS (K124067)

--- Page 11 ---
Similarities
Item Device Predicate Predicate
Bruker Daltonics,
Bruker Daltonics, Inc MBT-CA System VITEK MS (K124067) Inc MBT-CA
(K142677) System (K130831)
groups are retained. When between 1.70 and
more than four organisms or <2.00.
organism groups are found, or
when no match is found, the
organism is considered
unidentified.
Matching Calculates matches by comparing a new Uses a proprietary process Calculates matches
Algorithm spectrum called "mass binning.” In this by comparing a
against each single reference entry of a process, the spectrum new spectrum
reference database. between 3,000 and 17,000 against each single
Daltons are divided into 1300 reference entry of a
pre-defined reference database.
intervals called “bins”. Next,
an algorithm based on
supervised machine learning
known as the “Advanced
Spectrum Classifier”, is used
to determine how informative
each bin was in
differentiating that species
from all other species in the
database.
Recorded 2,000 - 20,000 m/z 2,000 - 20,000 m/z 2,000 - 20,000 m/z
Mass
Range
Calibration Bruker US IVD Bacterial Test Standard See “Differences” Bruker US IVD
(BTS) Bacterial Test
Standard (BTS)
MALDI US IVD 48 Spot Target See “Differences” US IVD 48 Spot
Target with 48 positions reusable steel targets Target
Plate with 48 positions
reusable steel
targets
MALDI- Bruker microflex (benchtop) See “Differences” Bruker microflex
TOF MS (benchtop)
Instruments
Database MALDI Biotyper for Clinical See “Differences” MALDI Biotyper
Applications (MBT-CA) for Clinical
Applications
(MBT-CA)
Differences
Item Device Predicate Predicate
Bruker Daltonics, Inc
Bruker Daltonics, Inc MBT-CA VITEK MS (K124067) MBT-CA System
System (K142677) (K130831)
Culture Age Bacteria and yeasts growth should Bacteria and yeast growth Bacteria growth should
be between 18h to 48h (+12h should be between 24 to be between 18h to 36h
storage at RT) 72 hours.
Specific requirements:
• Bordetella: Incubation on BG
agar should not be longer than
24h (+12h storage at RT).
11

[Table 1 on page 11]
Similarities						
Item		Device		Predicate
VITEK MS (K124067)		Predicate
Bruker Daltonics,
Inc MBT-CA
System (K130831)
						
		Bruker Daltonics, Inc MBT-CA System				
		(K142677)				
				groups are retained. When
more than four organisms or
organism groups are found, or
when no match is found, the
organism is considered
unidentified.	between 1.70 and
<2.00.	
Matching
Algorithm	Calculates matches by comparing a new
spectrum
against each single reference entry of a
reference database.			Uses a proprietary process
called "mass binning.” In this
process, the spectrum
between 3,000 and 17,000
Daltons are divided into 1300
pre-defined
intervals called “bins”. Next,
an algorithm based on
supervised machine learning
known as the “Advanced
Spectrum Classifier”, is used
to determine how informative
each bin was in
differentiating that species
from all other species in the
database.	Calculates matches
by comparing a
new spectrum
against each single
reference entry of a
reference database.	
Recorded
Mass
Range	2,000 - 20,000 m/z			2,000 - 20,000 m/z	2,000 - 20,000 m/z	
Calibration	Bruker US IVD Bacterial Test Standard
(BTS)			See “Differences”	Bruker US IVD
Bacterial Test
Standard (BTS)	
MALDI
Target
Plate	US IVD 48 Spot Target
with 48 positions reusable steel targets			See “Differences”	US IVD 48 Spot
Target
with 48 positions
reusable steel
targets	
MALDI-
TOF MS
Instruments	Bruker microflex (benchtop)			See “Differences”	Bruker microflex
(benchtop)	
Database	MALDI Biotyper for Clinical
Applications (MBT-CA)			See “Differences”	MALDI Biotyper
for Clinical
Applications
(MBT-CA)	

[Table 2 on page 11]
Predicate

VITEK MS (K124067)

[Table 3 on page 11]
Differences						
Item		Device		Predicate
VITEK MS (K124067)		Predicate
						Bruker Daltonics, Inc
		Bruker Daltonics, Inc MBT-CA				MBT-CA System
		System (K142677)				(K130831)
Culture Age	Bacteria and yeasts growth should
be between 18h to 48h (+12h
storage at RT)
Specific requirements:
• Bordetella: Incubation on BG
agar should not be longer than
24h (+12h storage at RT).			Bacteria and yeast growth
should be between 24 to
72 hours.	Bacteria growth should
be between 18h to 36h	

[Table 4 on page 11]
Predicate

VITEK MS (K124067)

--- Page 12 ---
Differences
Item Device Predicate Predicate
Bruker Daltonics, Inc
Bruker Daltonics, Inc MBT-CA VITEK MS (K124067) MBT-CA System
System (K142677) (K130831)
• Campylobacter: Incubation can
be prolonged to 72h (+12h
storage at RT).
• Streptococcus pneumoniae:
Incubation should not be longer
than 24h (+12h storage at RT)
due to possible autolysis.
Calibration Bruker US IVD Bacterial Test E. coli ATCC 8739 See “Similarities”
Standard (BTS)
MALDI US IVD 48 Spot Target VITEK MS-DS Target See “Similarities”
Target Plate with 48 positions reusable steel Slides
targets _ 48 positions disposable
plastic targets
MALDI-TOF Bruker microflex Shimadzu AXIMAR See “Similarities”
MS (benchtop) Assurance MS
Instrument (floor standing)
Database MALDI Biotyper for Clinical VITEKR MS V2.0 See “Similarities”
Applications (MBT-CA) Knowledge Base
Intended Use The Bruker Daltonics, Inc. See “Similarities” The Bruker Daltonics,
MALDI Biotyper CA System Inc MALDI Biotyper
is a mass spectrometer system CA System is a
using matrix-assisted qualitative in vitro
laser desorption/ionization – time- diagnostic mass
of-flight (MALDI-TOF) spectrometer system
for the identification of for the identification of
microorganisms cultured from Gram-negative bacterial
human specimens. colonies cultured from
The MALDI Biotyper CA System human specimens using
is a qualitative in vitro diagnostic matrix-assisted laser
device indicated for use in desorption/ ionization -
conjunction with other clinical and time of flight (MALDI-
laboratory findings to aid in TOF) mass spectrometry
the diagnosis of bacterial and yeast technology. The MALDI
infections. Biotyper CA System is
indicated for use in
conjunction with other
clinical and laboratory
findings to aid in the
diagnosis of Gram-
negative bacterial
infections.
K. Standard/Guidance Document Referenced (if applicable):
Standards Recognition Standards Title Date
No. No.(FDA)
1 CLSI MM- 7-192 Criteria for Identification of Bacteria and 4/28/2008
18A Fungi by DNA Target Sequencing; Approved
Guideline, 1st Edition
12

[Table 1 on page 12]
Differences							
Item		Device		Predicate
VITEK MS (K124067)		Predicate	
						Bruker Daltonics, Inc	
		Bruker Daltonics, Inc MBT-CA				MBT-CA System	
		System (K142677)				(K130831)	
	• Campylobacter: Incubation can
be prolonged to 72h (+12h
storage at RT).
• Streptococcus pneumoniae:
Incubation should not be longer
than 24h (+12h storage at RT)
due to possible autolysis.						
Calibration	Bruker US IVD Bacterial Test
Standard (BTS)			E. coli ATCC 8739	See “Similarities”		
MALDI
Target Plate	US IVD 48 Spot Target
with 48 positions reusable steel
targets			VITEK MS-DS Target
Slides
_ 48 positions disposable
plastic targets	See “Similarities”		
MALDI-TOF
MS
Instrument	Bruker microflex
(benchtop)			Shimadzu AXIMAR
Assurance MS
(floor standing)	See “Similarities”		
Database	MALDI Biotyper for Clinical
Applications (MBT-CA)			VITEKR MS V2.0
Knowledge Base	See “Similarities”		
Intended Use	The Bruker Daltonics, Inc.
MALDI Biotyper CA System
is a mass spectrometer system
using matrix-assisted
laser desorption/ionization – time-
of-flight (MALDI-TOF)
for the identification of
microorganisms cultured from
human specimens.
The MALDI Biotyper CA System
is a qualitative in vitro diagnostic
device indicated for use in
conjunction with other clinical and
laboratory findings to aid in
the diagnosis of bacterial and yeast
infections.			See “Similarities”	The Bruker Daltonics,
Inc MALDI Biotyper
CA System is a
qualitative in vitro
diagnostic mass
spectrometer system
for the identification of
Gram-negative bacterial
colonies cultured from
human specimens using
matrix-assisted laser
desorption/ ionization -
time of flight (MALDI-
TOF) mass spectrometry
technology. The MALDI
Biotyper CA System is
indicated for use in
conjunction with other
clinical and laboratory
findings to aid in the
diagnosis of Gram-
negative bacterial
infections.		

[Table 2 on page 12]
Predicate

VITEK MS (K124067)

[Table 3 on page 12]
	Standards
No.	Recognition
No.(FDA)	Standards Title	Date
1	CLSI MM-
18A	7-192	Criteria for Identification of Bacteria and
Fungi by DNA Target Sequencing; Approved
Guideline, 1st Edition	4/28/2008

--- Page 13 ---
L. Test Principle:
Organisms to be identified with the MALDI Biotyper CA System are isolated using the
appropriate isolation media. Users are instructed to first test the organism using the direct
transfer technique; if results are less than <2.0 log(score), users are then directed to perform
extraction procedure.
Direct Transfer (DT): An individual colony from an overnight subculture plate is
transferred to a selected position on an US IVD 48 Spot Target (target). The target is air
dried and US IVD HCCA portioned (matrix) is added. The standard solvent (50%
acetonitrile / 47.5% H O / 2.5% trifluoroacetic acid) in the matrix solution extracts
2
proteins (mainly ribosomal proteins, which are present in high concentration) from the
microorganisms. When dried matrix crystallizes, the inoculated target is ready to be
analyzed on the MALDI Biotyper CA System.
extended Direct Transfer (eDT): An isolated colony of bacteria or yeast is transferred as
a thin film directly onto a sample position on a cleaned target. The sample spot is
overlayed with 1 μL 70% aqueous formic acid directly on the target plate and allowed to
dry at room temperature. Afterwards the spots are overlayed with US IVD HCCA
portioned (matrix) and allowed to dry. When dried matrix crystallizes, the inoculated
target is ready to be analyzed on the MALDI Biotyper CA System.
Extraction Procedure (Ext): For this purpose, isolated colonies from the overnight
subculture plate are extracted using an ethanol/formic acid procedure. Afterwards they
are transferred to the target plate and allowed to dry. Afterwards the spots are overlayed
with US IVD HCCA portioned (matrix) and allowed to dry. When dried matrix
crystallizes, the inoculated target is ready to be analyzed on the MALDI Biotyper CA
System.
Samples are analyzed using MALDI (matrix-assisted laser desorption/ionization) TOF (time-
of-flight) mass spectrometry. The matrix transfers protons onto the extracted proteins and
absorbs UV light. After complete drying, the mixture is exposed to laser pulses, resulting in
energy transfer from the matrix causing evaporation and release of positively charged intact
proteins and peptides ("soft" ionization technique). The ionized molecules are accelerated by
electrical potentials through a flight tube to the mass spectrometer, with separation of the
particles determined by their mass/charge ratio (m/z). As different proteins/peptides have
different masses, ions arrive at the detector at different times (time of flight). The system
measures the time (in the nanosecond range) between pulsed acceleration and the
corresponding detector signal, the speed is converted into an exact molecular mass. The
mass-to-charge ratio of an ion is proportional to the square of its drift time. Highly abundant
microbial proteins (mainly ribosomal proteins) result in a mass spectrum with characteristic
mass and intensity distribution. It is species-specific for many bacteria and is interpreted as a
molecular fingerprint to identify the test organism. Data acquisition is controlled with
MALDI Biotyper CA System Software. The spectrum of the unknown organism is first
transformed into a peak list. This peak list is compared to the reference peak list of each
organism found in the reference library (database) and a log(score) is generated. A higher
log(score) indicates a higher degree of similarity to the organism in the reference library.
Organism identification is reported with high confidence if the log(score) is ≥ 2.00. An
organism identification is reported with low confidence if the log(score) is between 1.70 and
<2.00.
13

--- Page 14 ---
If different specimen identifications are obtained via different sample preparation techniques
(DT v. eDT v. Ext), testing should be repeated from a new colony from the same isolation
plate (assuming plate is <12 hours old). If after repeat, concordance is still not obtained,
additional testing using traditional laboratory methods and clinical presentation is
recommended for final organism identification.
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
a. Precision/Reproducibility:
The precision/repeatability study for Gram negative bacteria was successfully
performed and reported in 510(k) K130831. The precision study was conducted for
six (6) days with two (2) runs each day, two (2) operators, two (2) microflex LT/SH
instrument and two (2) target plates.
Table: Overall Precision per Test Organism: High Confidence ID (>2.0)
# # samples # samples # samples >2.00
Test organism samples >2.00 ID (DT) >2.00 ID (eDT) ID (DT/eDT+Ext)
measured
Brevibacterium casei 36 36 (100%) 36 (100%) 36 (100%)
Enterococcus faecalis 36 34 (94%) 36 (100%) 36 (100%)
Micrococcus luteus 36 21 (58%) 36 (100%) 36 (100%)
Staphylococcus aureus 36 36 (100%) 36 (100%) 36 (100%)
Staphylococcus epidermidis 36 36 (100%) 36 (100%) 36 (100%)
Streptococcus agalactiae 36 34 (94%) 36 (100%) 36 (100%)
Candida albicans 36 18 (50%) 30 (83%) 36 (100%)
Candida parapsilosis 36 6 (17%) 32 (89%) 36 (100%)
Candida tropicalis 36 34 (94%) 35 (97%) 36 (100%)
Saccharomyces cerevisiae 36 20 (56%) 27 (75%) 36 (100%)
The reproducibility study for Gram-positive aerobic bacteria, Gram-negative
microaerophilic bacteria, Gram-positive anaerobic bacteria, Gram-negative anaerobic
bacteria and yeast organisms was performed at three different clinical study sites. The
study was conducted for five (5) days with two (2) runs (two (2) operators) each day
per testing site with at least four (4) target plates/each clinical study site and a total of
four (4) microflex LT/SH instruments.
For all study processes described above, the following ten (10) blinded reproducibility
test organisms were tested:
Enterococcus faecalis Clostridium perfringens
Staphylococcus epidermidis Propionbacterium acnes
Streptococcus agalactiae Candida albicans
Bacteroides fragilis Saccharomyces cerevisiae
Fusobacterium necrophorum Cryptococcus neoformans var grubii
14

[Table 1 on page 14]
	#	# samples	# samples	# samples >2.00
Test organism	samples	>2.00 ID (DT)	>2.00 ID (eDT)	ID (DT/eDT+Ext)
	measured			
				
Brevibacterium casei	36	36 (100%)	36 (100%)	36 (100%)
Enterococcus faecalis	36	34 (94%)	36 (100%)	36 (100%)
Micrococcus luteus	36	21 (58%)	36 (100%)	36 (100%)
Staphylococcus aureus	36	36 (100%)	36 (100%)	36 (100%)
Staphylococcus epidermidis	36	36 (100%)	36 (100%)	36 (100%)
Streptococcus agalactiae	36	34 (94%)	36 (100%)	36 (100%)
Candida albicans	36	18 (50%)	30 (83%)	36 (100%)
Candida parapsilosis	36	6 (17%)	32 (89%)	36 (100%)
Candida tropicalis	36	34 (94%)	35 (97%)	36 (100%)
Saccharomyces cerevisiae	36	20 (56%)	27 (75%)	36 (100%)

--- Page 15 ---
All organisms were tested via Direct Transfer (DT) and extended Direct Transfer (eDT)
methods in duplicate (each method/each test organism) across two instrument runs (one
by each operator) for five (5) testing days (each clinical study site) in accordance with
product instructions for use. If DT and/or eDT results log(score) were <2.0, the test
organism was tested via the Extraction technique (Ext) in duplicate in accordance with
product instructions.
During the course of the five (5) day Reproducibility Panel testing, a total of forty (40)
MALDI Biotyper identifications (20 ID’s for DT and 20 ID’s for eDT technique) for each
test-organism at each clinical site were carried out [each organism x 2 replicates x 2
operators x 5 days].
Table: Overall Reproducibility Panel Testing per Test Organism using ≥2.0 MBT-CA scores
Blinded Test Organism Reproducibility ≥2.0 ID ≥2.0 ID ≥2.0 ID
Panel (DT) (eDT) (DT+eDT+Ext)
Enterococcus faecalis REPRO-1 60/60 (100%) 60/60 (100%) 60/60 (100%)
Staphylococcus epidermidis REPRO-2 58/60 (97%) 59/60 (98%) 60/60 (100%)
Streptococcus agalactiae REPRO-3 58/60 (97%) 55/60 (92%) 60/60 (100%)
Bacteroides fragilis REPRO-4 60/60 (100%) 60/60 (100%) 60/60 (100%)
Fusobacterium necrophorum REPRO-5 56/60 (93%) 53/60 (88%) 58/60 (97%)
Clostridium perfringens REPRO-6 53/60 (88%) 58/60 (97%) 59/60 (98%)
Propionibacterium acnes REPRO-7 53/60 (88%) 49/60 (82%) 60/60 (100%)
Candida albicans REPRO-8 33/60 (55%) 41/60 (68%) 60/60 (100%)
Saccharomyces cerevisiae REPRO-9 5/60 (8%) 0/60 (0%) 31/60 (52%)
Cryptococcus neoformans var
REPRO-10 31/60 (52%) 44/60 (73%) 53/60 (88%)
grubii
In total, 60 MALDI Biotyper CA identifications of each test-organism for each of DT and
eDT methods were performed. All reproducibility isolates passed established acceptance
criteria and no isolates were falsely identified.
The reproducibility study for aerobic Gram-negative bacteria was previously reported in
510(k) K130831.
15

[Table 1 on page 15]
Blinded Test Organism		Reproducibility			≥2.0 ID			≥2.0 ID			≥2.0 ID	
		Panel			(DT)			(eDT)			(DT+eDT+Ext)	
Enterococcus faecalis	REPRO-1			60/60 (100%)			60/60 (100%)			60/60 (100%)		
Staphylococcus epidermidis	REPRO-2			58/60 (97%)			59/60 (98%)			60/60 (100%)		
Streptococcus agalactiae	REPRO-3			58/60 (97%)			55/60 (92%)			60/60 (100%)		
Bacteroides fragilis	REPRO-4			60/60 (100%)			60/60 (100%)			60/60 (100%)		
Fusobacterium necrophorum	REPRO-5			56/60 (93%)			53/60 (88%)			58/60 (97%)		
Clostridium perfringens	REPRO-6			53/60 (88%)			58/60 (97%)			59/60 (98%)		
Propionibacterium acnes	REPRO-7			53/60 (88%)			49/60 (82%)			60/60 (100%)		
Candida albicans	REPRO-8			33/60 (55%)			41/60 (68%)			60/60 (100%)		
Saccharomyces cerevisiae	REPRO-9			5/60 (8%)			0/60 (0%)			31/60 (52%)		
Cryptococcus neoformans var
grubii	REPRO-10			31/60 (52%)			44/60 (73%)			53/60 (88%)		

--- Page 16 ---
b. Linearity/assay reportable range:
Not applicable, qualitative assay.
c. Traceability, Stability, Expected values (controls, calibrators, or methods):
US IVD BTS is used for mass spectrum calibration and optimization as well as a
performance control for the identification of microorganisms with the MALDI
Biotyper CA System. US IVD BTS contains a manufactured extract of Escherichia
coli DH5 alpha that demonstrates a characteristic peptide and protein profile mass
spectrum, when tested on the MALDI Biotyper CA System. US IVD BTS is spiked
with two additional proteins that extend the upper boundary of the mass range of the
US IVD BTS. The overall mass range covered by US IVD BTS is 3.6 to 17 kDa. Two
US IVD BTS control positions on a US IVD 48 Spot Target are selected and
inoculated with US IVD BTS solution. The US IVD BTS solution is allowed to dry at
room temperature and then overlayed with reconstituted US IVD HCCA portioned
solution. If US IVD BTS does not meet all required performance specifications, the
test run will be invalid. If US IVD BTS is not inoculated onto a target prior to
processing, the test run will be invalid.
Controls:
The external control organism testing is outlined below:
• Gram-Negative (aerobic/anaerobic) Test Organism: Run one (1) of the Gram-
Negative QC organisms via whatever testing methodology is included on the
target plate (i.e., DT, eDT or Ext)
• The Haemophilus Quality control organism should be tested only if the site is
testing an organism suspected to be a Haemophilus.
• Gram-Positive (aerobic/anaerobic) Test Organism: Run one (1) of the Gram-
Positive QC organisms via whatever testing methodology is included on the
target plate (i.e., DT, eDT or Ext)
• Yeast Test Organism: Run one (1) of the Gram-Positive QC organisms via
whatever testing methodology is included on the target plate (i.e., DT, eDT or
Ext).
The following external quality control test organisms were included in the clinical
trial:
For Gram-negative bacteria:
• Enterobacter cloacae: ATCC: 13047 = DSM 30054
• Klebsiella pneumoniae: ATCC: 13883 = DSM 30104
• Proteus vulgaris: ATCC: 29905 = DSM 13387
• Pseudomonas aeruginosa: ATCC: 10145 = DSM 50071
• Escherichia coli: ATCC: 25922 = DSM 1103
16

--- Page 17 ---
For Haemophilus samples:
• Haemophilus influenzae: ATCC: 49766 = DSM 11970 (for Chocolate
Agar)
For Gram positive bacteria:
• Enterococcus faecalis: ATCC: 17433T = DSM 20478T
• Enterococcus faecium: ATCC: 19434T = DSM 20477T
• Staphylococcus aureus: ATCC: 12600T = DSM 20231T
If the QC organism is not correctly identified or yields a log(score) <2.00, the run was
considered invalid. All isolates and QC organisms were re-spotted using a new target
plate and testing repeated.
Of the 795 Quality Control runs conducted during the course of the method
comparison study, there were forty (40) instances where a Quality Control organism
failed to yield an expected result. As a result, all isolates included in that plate run for
the appropriate methodology were repeated using a fresh QC organism transfer. The
overall plate repeat rate was 5.0% (40/795). All repeat testing of QC organisms
provided valid results.
d. Limit of Detection/Dynamic Range:
The Limit of Detection study was conducted to estimate the dynamic range (in terms
of sample amount) of Gram-positive bacteria and yeasts to be identified on the
MALDI Biotyper CA System. Six (6) frequently occurring clinically relevant test
organisms [three (3) Gram-positive and three (3) yeast] were chosen for this study.
[NOTE: Due to the nature of yeast organisms, dynamic range studies using known
yeast concentration were not feasible for the Direct Transfer procedure].
Turbidity measurements of stock suspensions containing microbial material were
performed at a wavelength of 600 nm. To verify the concentration of the organisms in
the dilutions, the stock suspensions of each test-organism were diluted in a series of
1:10 dilutions resulting in a final dilution of 107 (Gram-positive bacteria) and 106
(yeasts). To account for random errors, the determination of each suspension’s
concentration in CFU/µL containing microbial material was done in triplicate. All
suspensions were tested in replicates of eight (8) via each testing methodology (Direct
(DT), extended Direct (eDT) and Extraction (EXT)).
Table: Organism Dynamic range for the Direct, extended Direct and Extraction procedures
DT eDT EXT
Lower Upper Lower Upper Lower Upper
Test Organism limit limit limit limit limit limit
[CFU/µL] [CFU/µL] [CFU/µL] [CFU/µL] [CFU/µL] [CFU/µL]
Enterococcus faecalis 1.2 x 106 6.0 x 107 3.6 x 106 1.8 x 108 3.6 x 106 1.8 x 108
Enterococcus faecium 4.5 x 107 4.5 x 107 2.1 x 106 1.1 x 108 2.1 x 106 1.1 x 108
17

[Table 1 on page 17]
	DT						eDT						EXT					
Test Organism		Lower			Upper			Lower			Upper			Lower			Upper	
		limit			limit			limit			limit			limit			limit	
		[CFU/µL]			[CFU/µL]			[CFU/µL]			[CFU/µL]			[CFU/µL]			[CFU/µL]	
Enterococcus faecalis	1.2 x 106			6.0 x 107			3.6 x 106			1.8 x 108			3.6 x 106			1.8 x 108		
Enterococcus faecium	4.5 x 107			4.5 x 107			2.1 x 106			1.1 x 108			2.1 x 106			1.1 x 108		

--- Page 18 ---
DT eDT EXT
Lower Upper Lower Upper Lower Upper
Test Organism limit limit limit limit limit limit
[CFU/µL] [CFU/µL] [CFU/µL] [CFU/µL] [CFU/µL] [CFU/µL]
Staphylococcus aureus 3.5 x 105 1.8 x 108 4.1 x 104 2.1 x 108 4.1 x 105 2.1 x 108
Candida albicans N/A N/A 2.0 x 105 2.0 x 106 2.0 x 106 1.0 x 107
Candida parapsilosis N/A N/A 2.5 x 105 2.5 x 106 2.5 x 106 1.3 x 107
Saccharomyces cerevisiae N/A N/A 1.5 x 105 1.5 x 106 1.5 x 105 7.5 x 106
When testing at the extremes of the defined dynamic range for all organisms tested,
no incorrect MALDI Biotyper CA identifications were reported. Results at the
extremes were reported as “No Peaks” or “No Identification” (i.e., no false results
were reported.)
e. Analytical specificity:
To confirm specificity, all organism spectra in the MBT-CA database (179
bacteria/group/complex claims with 5-74 strains per each organism/group/complex
and 31 yeasts with 5-14 strains per each organism for a total of 2020 spectra) and
MBT-non-clinically validated databases (930 microorganisms (1-16 strains each) for
a total of 1999 spectra) were cross-checked in silico against each other. If an
indication for the possibility of cross-matching patterns was found, the organism was
included in the matching hint table found in the package labelling.
f. Assay cut-off:
Using statistical analysis, a probability ranking of the organism identification is
generated. The probability ranking is represented as a log (score) between 0.00 and
3.00.
Organism identification (direct or extracted) is reported with high confidence if the
log(score) is ≥ 2.00. If a direct transfer organism identification log(score) is <2.00;
the user is instructed to follow and extraction procedure (eDT or EXT).
After extraction:
• If the organism identification log(score) is between 1.7 and <2.0, the
identification is reported as low confidence.
• If the organism identification log(score) is <1.7, it is reported as ‘No
Identification’.
Some MBT-CA identifications results are non-clinically validated organisms and are
displayed in the MBT-CA report in the interest of public health as a means of
directing the required additional laboratory testing. Non-clinically validated organism
results are created from reference patterns which have not been clinically validated.
‘No Identification’ is reported based on the validated reference pattern (MSP) library
if a result from the non-clinically validated reference pattern (MSP) library was found
18

[Table 1 on page 18]
	DT						eDT						EXT					
Test Organism		Lower			Upper			Lower			Upper			Lower			Upper	
		limit			limit			limit			limit			limit			limit	
		[CFU/µL]			[CFU/µL]			[CFU/µL]			[CFU/µL]			[CFU/µL]			[CFU/µL]	
Staphylococcus aureus	3.5 x 105			1.8 x 108			4.1 x 104			2.1 x 108			4.1 x 105			2.1 x 108		
Candida albicans	N/A			N/A			2.0 x 105			2.0 x 106			2.0 x 106			1.0 x 107		
Candida parapsilosis	N/A			N/A			2.5 x 105			2.5 x 106			2.5 x 106			1.3 x 107		
Saccharomyces cerevisiae	N/A			N/A			1.5 x 105			1.5 x 106			1.5 x 105			7.5 x 106		

--- Page 19 ---
to yield a higher log(score) value. The non-clinically validated result is added as a
comment (grey in square brackets) below the ‘No Identification’ result. Identification
of non-clinically validated organisms must be performed with an alternate laboratory
method. Results for non-clinically validated organisms cannot be transmitted from the
MBT-CA to the laboratory information system.
The log(score) value ranges defined in the MALDI Biotyper CA System reflect the
probability of organism identification. Results should be reviewed by a trained
microbiologist and final organism identification should be based on all relevant
information available. This information includes, but is not limited to, Gram staining,
colony morphology, growth characteristics, sample matrix, or other factors that might
impact organism identification.
g. Stability studies (reagent/target plates):
US IVD Bacterial Test Standard (BTS) - see K130831
HCCA portioned (Matrix) Stability - see K130831
Target plate stability - see K130831
h. Carry-Over and Cross Contamination: See K130831
i. Influence of Agar Media
Testing was conducted using three (3) Gram-positive bacteria, three (3) yeasts, five
(5) anaerobic bacteria, two (2) Campylobacter and three (3) Bordetella species at
varying incubation time points in replicates of eight (8). After initial testing, isolates
were further tested at room temperature after twelve (12) hours post-incubation.
• Chocolate Agar (CHOC)
T•h
C
e
o
fo
lu
ll
m
ow
bi
i
a
n
C
g
N
m
A
ed
a
i
g
a
a
w
r w
er
i
e
th
t e
5
s
%
te
s
d
h
:
e ep blood (CNA)
• Brucella Agar with 5% horse blood (BRU)
• CDC anaerobe Agar with 5% sheep blood (CDC)
• CDC anaerobe 5% sheep blood Agar with phenylethyl alcohol (CDC/PEA)
• CDC anaerobe laked sheep blood Agar with kanamycin and vancomycin
(CDC/LKV)
• Bacteroides bile esculin Agar with amikacin (BBE)
• Clostridium difficile Agar with 7% sheep blood (CDA)
• Trypticase Soy Agar with 5% sheep blood (TSA)
• Sabouraud-Dextrose Agar (SDA)
• Brain-Heart Infusion Agar (BHI)
• Campylobacter Agar with 5 Antimicrobics and 10% sheep blood (CAMPY BAP)
• Bordet Gengou Agar with 15% sheep blood (BGA)
• Columbia Blood Agar with 5% sheep blood (CBA)
19

--- Page 20 ---
Study results demonstrate for measurement in the MALDI Biotyper CA System,
isolates must be tested from a fresh culture - 18-48 hours incubation - or 12 hours
post incubation at room temperature (total 60 hours). Specific requirements:
• Bordetella: Incubation on BG agar should not be longer than 24h (+12h storage at
RT).
• Campylobacter: Incubation can be prolonged to 72h (+12h storage at RT).
• Streptococcus pneumoniae: Incubation should not be longer than 24h (+12h
storage at RT) due to possible autolysis.
The following media were previously validated and reported in 510(k) K130831:
• Trypticase Soy Agar with 5% sheep blood (TSA)
• Columbia Blood Agar with 5% sheep blood (CBA)
• MacConkey Agar (MAC)
• Chocolate Agar (Choc)
j. Organism Stability prior to MALDI Biotyper CA System Analysis
The organism stability study for Gram-negative bacteria prior to MALDI Biotyper
CA analysis was previously validated and reported in 510(k) K130831.
Gram-positive samples are stable on the target plate using both Direct Transfer and
Extraction procedure for up to 60 minutes prior to matrix addition. In addition, the
study confirmed that extracts are stable for up to 24 hours when stored at room
temperature. The study and subsequent results confirm that yeast samples are stable
on the target plate via Direct Transfer, extended Direct Transfer and Extraction
method for up to 30 minutes prior to matrix addition. In addition, the study
confirmed that extracts are stable for up to 4 hours when stored at room temperature.
k. Validation of extended Direct Transfer Technique
This study served to validate the extended Direct Transfer technique (eDT) for Gram-
negative bacteria, Gram-positive bacteria and yeasts. Stability of directly transferred
test organisms on the target plate in combination with delayed 70% aqueous formic
acid addition and/or delayed matrix addition at ambient temperature (23 ± 2)°C prior
to MALDI Biotyper CA analysis were performed. To validate extended Direct
Transfer technique prior to MALDI Biotyper CA analysis, the following Gram-
negative, Gram-positive and yeast organisms were cultured on Trypticase Soy Agar
(TSA) and tested:
Test Organism DSM Strain
Escherichia coli 1103
Pseudomonas aeruginosa 50071
Proteus vulgaris 13387
Enterococcus faecalis 20478T
Enterococcus faecium 20477T
20

[Table 1 on page 20]
Test Organism	DSM Strain
Escherichia coli	1103
Pseudomonas aeruginosa	50071
Proteus vulgaris	13387
Enterococcus faecalis	20478T
Enterococcus faecium	20477T

--- Page 21 ---
Staphylococcus aureus 20231T
Candida albicans 1665
Candida parapsilosis 5784T
Saccharomyces cerevisiae 70449T
The study results confirmed sample stability and MALDI Biotyper CA identification
for the following settings:
• Directly transferred microbial material on MALDI target plates in
combination with a delay of up to 2 h for 70% aqueous formic acid addition at
(23 ± 2)°C.
• Extended Direct Transfer method in combination with a delay of up to 2 h for
HCCA matrix addition at (23 ± 2)°C.
• Delayed (up to 2 h) extended Direct Transfer method in combination with
delayed (up to 2 h) HCCA matrix addition at (23± 2)°C.
l. Sample Stability Overlaid with Matrix
The sample stability study on target plates for Gram-negative bacteria was previously
validated and reported in 510(k) K130831.
To test the stability of test organisms in matrix after inoculation of the target the
following Gram-positive bacteria and yeasts were selected and tested:
Test Organism DSM Strain
T
Enterococcus faecalis 20478
T
Enterococcus faecium 20477
T
Staphylococcus aureus 20231
Candida albicans 1665
T
Candida parapsilosis 5784
T
Saccharomyces cerevisiae 70449
All study results confirmed that inoculated test organisms once overlaid with matrix
are stable for up to 24 hours at room temperature (20 – 25°C).
m. Other supportive Instrument Performance Characteristics
Mixed Culture: See K130831
Viability Study: Viability studies with organisms mixed with matrix on the target
plate were not performed. The user is advised to consider all samples, microbial
cultures and inoculated products as infectious. Aseptic techniques and usual
precautions for handling organisms should be observed throughout the MALDI
Biotyper CA System workflow according to "CLSI M29-A, Protection of Laboratory
Workers from Occupationally Acquired Infections; Approved Guideline - Current
revision". For additional handling precautions, refer to "Biosafety in Microbiological
and Biomedical Laboratories - CDC/NIH -Latest edition".
21

[Table 1 on page 21]
Staphylococcus aureus	20231T
Candida albicans	1665
Candida parapsilosis	5784T
Saccharomyces cerevisiae	70449T

[Table 2 on page 21]
Test Organism	DSM Strain
Enterococcus faecalis	T
20478
Enterococcus faecium	T
20477
Staphylococcus aureus	T
20231
Candida albicans	1665
Candida parapsilosis	T
5784
Saccharomyces cerevisiae	T
70449

--- Page 22 ---
2. Comparison studies:
a. Method comparison with predicate device:
Not applicable. Refer to the Clinical Studies section of this document.
b. Matrix comparison:
Not applicable
3. Clinical studies:
a. Clinical Sensitivity:
Proficiency/Familiarity
Prior to a site starting the clinical study, new sites (i.e., sites that did not participate in
K130831) were trained on the MBT-CA System. All sites (including those previously
involved in the K130831 study) will test a panel of organisms using "Direct Transfer
procedure" (DT), "extended Direct Transfer procedure" (eDT), and Extraction (EXT)
procedure. All operators responsible for testing during the study will participate in an
initial five day proficiency testing period. Samples tested included a panel of Gram-
positive quality control organisms. Samples tested also included Gram-negative
quality control organisms for operators that did not participate in the proficiency
testing for K130831 (i.e., new sites).
Challenge Panel
A panel of 55 organisms (24 Gram-positive aerobic bacteria, one (1) Gram-negative
microaerophilic bacterium, four Gram-negative anaerobic bacteria, six (6) Gram-
positive anaerobic bacteria, 20 yeasts) was tested at four (4) study sites. The study
reference laboratory, prepared the panel. Organism identifications were blinded to test
sites. Each site tested the challenge panel member via direct transfer and extended
direct transfer method in accordance with product instructions. If DT and/or eDT
result yielded a log(score) <2.00, the organism was retested using the Extraction
method. No incorrect identifications occurred. A total 93% of test organisms were
correctly identified with a log(score) > 2 result applying the MBT-CA workflow.
Table: Challenge Panel Study Summary
Site A Site B Site C Site D Sites A - D
Test procedure
≥2.0 ID ≥2.0 ID ≥2.0 ID ≥2.0 ID ≥2.0 ID
46/55 47/55 35/55 36/55 164/220
DT method
(84%) (85%) (64%)* (65%) (75%)
47/55 50/55 ( 44/55 43/55 184/220
eDT method
(85%) 91%) (80%)* (78%) (84%)
54/55 53/55 49/55 37/55 193/220
Ext method
(98%) (96%) (89%) (67%) (88%)
Overall MBT-CA 54/55 55/55 49/55 46/55 204/220
workflow (98%) (100%) (89%) (84%) (93%)
* One sample was incorrectly identified due to a mixed culture.
22

[Table 1 on page 22]
	Test procedure			Site A			Site B			Site C			Site D			Sites A - D	
				≥2.0 ID			≥2.0 ID			≥2.0 ID			≥2.0 ID			≥2.0 ID	
DT method			46/55
(84%)			47/55
(85%)			35/55
(64%)*			36/55
(65%)			164/220
(75%)		
eDT method			47/55
(85%)			50/55 (
91%)			44/55
(80%)*			43/55
(78%)			184/220
(84%)		
Ext method			54/55
(98%)			53/55
(96%)			49/55
(89%)			37/55
(67%)			193/220
(88%)		
Overall MBT-CA
workflow			54/55
(98%)			55/55
(100%)			49/55
(89%)			46/55
(84%)			204/220
(93%)		

--- Page 23 ---
Prospective Clinical Study:
Testing was performed at seven clinical sites using Direct Transfer (DT) and
extended Direct Transfer (eDT) of an organism to the target plate. If the MALDI
Biotyper CA System identification of the test organism did not result in a bacteria or
yeast identification with DT log(score) value of ≥2.00, repeat testing was performed
using the extraction procedure. Approximately 29% of all clinical results required
extraction.
The reference algorithm used in the clinical study was a composite of nucleic acid
sequencing using the cutoff values for percent identity scores and sequence analysis
(i.e., review of ambiguous bases, review of first 100 GenBank results) as set forth in
“CLSI MM18-A Criteria for Identification of Bacteria and Fungi by DNA Target
Sequencing”, protein sequencing, and biochemical testing. Due to similarities in
sequence and other biochemical characteristics, some organisms in the MBT-CA
claimed organism list could not be uniquely identified using the reference algorithm.
In these cases the reference algorithm was indicated as low resolution and a hint for
the unresolved species was listed in the Matching Hint Table found in the package
insert.
The following tables summarize MALDI Biotyper CA System results for the
prospective clinical study.
Table: Overall Performance of MBT-CA for All Organisms*
REFERENCE ALGORITHM
High Resolution Low Resolution Negative Total
Species Species/Genus
Organism ID ≥ 2.0 3817 392 18 1,2 4227
(High Confidence)
107 13 9 3,4 129
Organism ID
(≥1.7; <2.0)
(Low Confidence)
Incorrect MBT-CA ID (>1.7) 42 5 1 5 0 43
No ID (<1.7)
Total 3966 406 27 4399
*See Table below for organisms corresponding to footnotes
1. MBT-CA Organism ID >2.0; Correct genus ID - Incorrect species ID (13 isolates);
Reference Method reported a different organism.
2. MBT-CA Organism ID >2.0; Incorrect Genus (5 isolates);
Reference Method reported a different organism.
3. MBT-CA Organism ID (≥1.7 - <2.0); Correct genus ID - Incorrect species ID (8 isolates);
Reference Method reported a different organism.
4. MBT-CA Organism ID (≥1.7 - <2.0); Incorrect Genus (1 isolates);
Reference Method reported a different organism
5. MBT-CA Incorrect Organism ID >1.7; no ID <1.7 (43 isolates);
Reference Method reported a species from the included in the MBT-CA Reference Library.
23

[Table 1 on page 23]
	REFERENCE ALGORITHM			Total
	High Resolution
Species	Low Resolution
Species/Genus	Negative	
Organism ID ≥ 2.0
(High Confidence)	3817	392	18 1,2	4227
Organism ID
(≥1.7; <2.0)
(Low Confidence)	107	13	9 3,4	129
Incorrect MBT-CA ID (>1.7)
No ID (<1.7)	42 5	1 5	0	43
Total	3966	406	27	4399

--- Page 24 ---
FOOTNOTE MBT-CA RESULT REFERENCE ALGORITHM
Acinetobacter haemolyticus A.gyllenbergii
1
Acinetobacter johnsonii A.lwoffii
Acinetobacter junii A.venetianus
Chryseobacterium gleum C.bernardetii
Chryseobacterium gleum C.bernardetii
Chryseobacterium gleum C.indologenes
Rhizobium radiobacter R.nepotum
Rhizobium radiobacter R.massiliae
Rhizobium radiobacter O.anthropi
S.pneumoniae S.mitis / oralis
S.pneumoniae S.mitis / oralis
Staphylococcus haemolyticus S.intermedius
Streptococcus dysgalactiae S.canis
Bacteroides thetaiotaomicron P.distasonis
2
Campylobacter coli Shigella dysenteriae
Candida dubliniensis Lactobacillus casei
Prevotella buccae Slackia exigua
Staphylococcus epidermidis Actinomyces neuii
Chryseobacterium indologenes C.gleum
3
Enterobacter amnigenus E.asburiae
Enterococcus hirae E.durans
Peptoniphilus harei P.timonensis
Streptococcus dysgalactiae S.equi
Streptococcus gordonii S.lactarius
Streptococcus gordonii S.rubneri
Streptococcus gordonii S.parasanguinis
24

[Table 1 on page 24]
FOOTNOTE	MBT-CA RESULT	REFERENCE ALGORITHM
1	Acinetobacter haemolyticus	A.gyllenbergii
	Acinetobacter johnsonii	A.lwoffii
	Acinetobacter junii	A.venetianus
	Chryseobacterium gleum	C.bernardetii
	Chryseobacterium gleum	C.bernardetii
	Chryseobacterium gleum	C.indologenes
	Rhizobium radiobacter	R.nepotum
	Rhizobium radiobacter	R.massiliae
	Rhizobium radiobacter	O.anthropi
	S.pneumoniae	S.mitis / oralis
	S.pneumoniae	S.mitis / oralis
	Staphylococcus haemolyticus	S.intermedius
	Streptococcus dysgalactiae	S.canis
2	Bacteroides thetaiotaomicron	P.distasonis
	Campylobacter coli	Shigella dysenteriae
	Candida dubliniensis	Lactobacillus casei
	Prevotella buccae	Slackia exigua
	Staphylococcus epidermidis	Actinomyces neuii
3	Chryseobacterium indologenes	C.gleum
	Enterobacter amnigenus	E.asburiae
	Enterococcus hirae	E.durans
	Peptoniphilus harei	P.timonensis
	Streptococcus dysgalactiae	S.equi
	Streptococcus gordonii	S.lactarius
	Streptococcus gordonii	S.rubneri
	Streptococcus gordonii	S.parasanguinis

--- Page 25 ---
FOOTNOTE MBT-CA RESULT REFERENCE ALGORITHM
4 Staphylococcus haemolyticus Nosocomiicoccus ampullae
Corynebacterium aurimucosum C.aurimucosum
5
Corynebacterium aurimucosum C.aurimucosum
Corynebacterium aurimucosum C.singulare
Finegoldia magna F.magna
Kytococcus sedentarius K.sedentarius
Parabacteroides distasonis P.distasonis
Propionibacterium acnes P.acnes
Staphylococcus hominis S.hominis
Staphylococcus simulans S.simulans
Staphylococcus simulans S.simulans
Actinomyces odontolyticus A.odontolyticus
Aerococcus viridans A.urinaeequi
Aerococcus viridans A.urinaeequi
Aerococcus viridans A.urinaeequi
Aerococcus viridans A.urinaeequi
Aerococcus viridans A.urinaeequi
Aerococcus viridans A.urinaeequi
Aerococcus viridans A.urinaeequi
Aerococcus viridans A.urinaeequi
Aerococcus viridans A.urinaeequi
Aerococcus viridans A.urinaeequi
Corynebacterium aurimucosum C.singulare
Staphylococcus carnosus S.carnosus
Candida boidinii C.boidinii
Candida dubliniensis C.dubliniensis
Candida dubliniensis C.dubliniensis
Candida guilliermondii Meyerozyma caribbica
Candida guilliermondii Meyerozyma caribbica
Candida guilliermondii Meyerozyma caribbica
Candida guilliermondii Meyerozyma caribbica
Candida guilliermondii Meyerozyma caribbica
Candida lambica Pichia fermentans
Candida lambica Pichia fermentans
Candida metapsilosis C.metapsilosis
Candida tropicalis C.tropicalis
Candida tropicalis C.tropicalis
Cryptococcus neoformans var grubii C.neoformans
Cryptococcus neoformans var grubii C.neoformans
Geotrichum capitatum Geotrichum capitatum
Saccharomyces cerevisiae S.cerevisiae
Actinomyces neuii S. epidermidis
Streptococcus pneumoniae S. mitis / oralis group
Streptococcus pneumoniae S. mitis / oralis group
25

[Table 1 on page 25]
FOOTNOTE	MBT-CA RESULT	REFERENCE ALGORITHM
4	Staphylococcus haemolyticus	Nosocomiicoccus ampullae
5	Corynebacterium aurimucosum	C.aurimucosum
	Corynebacterium aurimucosum	C.aurimucosum
	Corynebacterium aurimucosum	C.singulare
	Finegoldia magna	F.magna
	Kytococcus sedentarius	K.sedentarius
	Parabacteroides distasonis	P.distasonis
	Propionibacterium acnes	P.acnes
	Staphylococcus hominis	S.hominis
	Staphylococcus simulans	S.simulans
	Staphylococcus simulans	S.simulans
	Actinomyces odontolyticus	A.odontolyticus
	Aerococcus viridans	A.urinaeequi
	Aerococcus viridans	A.urinaeequi
	Aerococcus viridans	A.urinaeequi
	Aerococcus viridans	A.urinaeequi
	Aerococcus viridans	A.urinaeequi
	Aerococcus viridans	A.urinaeequi
	Aerococcus viridans	A.urinaeequi
	Aerococcus viridans	A.urinaeequi
	Aerococcus viridans	A.urinaeequi
	Aerococcus viridans	A.urinaeequi
	Corynebacterium aurimucosum	C.singulare
	Staphylococcus carnosus	S.carnosus
	Candida boidinii	C.boidinii
	Candida dubliniensis	C.dubliniensis
	Candida dubliniensis	C.dubliniensis
	Candida guilliermondii	Meyerozyma caribbica
	Candida guilliermondii	Meyerozyma caribbica
	Candida guilliermondii	Meyerozyma caribbica
	Candida guilliermondii	Meyerozyma caribbica
	Candida guilliermondii	Meyerozyma caribbica
	Candida lambica	Pichia fermentans
	Candida lambica	Pichia fermentans
	Candida metapsilosis	C.metapsilosis
	Candida tropicalis	C.tropicalis
	Candida tropicalis	C.tropicalis
	Cryptococcus neoformans var grubii	C.neoformans
	Cryptococcus neoformans var grubii	C.neoformans
	Geotrichum capitatum	Geotrichum capitatum
	Saccharomyces cerevisiae	S.cerevisiae
	Actinomyces neuii	S. epidermidis
	Streptococcus pneumoniae	S. mitis / oralis group
	Streptococcus pneumoniae	S. mitis / oralis group

--- Page 26 ---
Performance table(s) abbreviation key:
• # Isolates (MM) – number of isolates used for multiple measurement testing (total
multiple measurements performed);
• Reference Algorithm (HIGH) - Reference Algorithm High Resolution
• Reference Algorithm (LOW) - Reference Low Resolution
Table: Overall Performance of MBT-CA for Organism Groups
Correct: Genus ID C o r r e c t: Genus ID
Correct: Species ID or I n correct: Species ID or Incorrect: Genus ID No ID
Group / Complex ID Group / Complex ID
MBT-CA M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A
> 2.0 >1.7 - <2.0 > 2.0 > 1.7 - < 2.0 > 2.0 > 1.7 - < 2.0 < 1.7
Reference R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e
Organism algorithm algorithm algorithm algorithm algorithm algorithm algorithm
High Low High Low High Low High Low High Low High Low High Low
All 3079 389 52 12 10 5 5 3 5 0 1 0 22 1
Bacteria 85.9% 10.9% 1.5% 0.3% 0.3% 0.1% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.6% 0.0%
738 3 55 1 0 0 0 0 1 0 0 0 17 0
All Yeast
90.6% 0.4% 6.7% 0.1% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 2.1% 0.0%
482 34 5 1 0 0 1 0 3 0 0 0 4 0
Anaerobes
90.8% 6.4% 0.9% 0.2% 0.0% 0.0% 0.2% 0.0% 0.6% 0.0% 0.0% 0.0% 0.8% 0.0%
Gram- 607 160 6 7 6 3 2 0 1 0 0 0 0 0
Negatives 76.6% 20.2% 0.8% 0.7% 0.8% 0.4% 0.3% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0%
Gram- 1990 195 41 4 4 2 2 3 1 0 1 0 18 1
Positives 88.0% 8.6% 1.8% 0.2% 0.2% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 80.0% 0.0%
Individual organism (measurand) performance is provided in the tables below. Due to the low
prevalence of some organisms, multiple measurements (replicates) of clinical study isolates were
tested by multiple testing sites to generate additional data to support performance of the MBT-
CA System. The number of clinical isolates used for replicate testing and the number of
replicates performed for that set of clinical isolates are listed in a column adjacent to the
prospective study performance results of all clinical isolates (i.e., clinical isolates without
replicate testing) for each organism claim. Results from the 3,802 replicate testing results were
reviewed separately from the method comparison isolates; multiple measurements were used as
supplementary data to support all claims.
26

[Table 1 on page 26]
	Correct: Genus ID
Correct: Species ID or
Group / Complex ID				C o r r e c t: Genus ID
I n correct: Species ID or
Group / Complex ID				Incorrect: Genus ID				No ID	
	MBT-CA
> 2.0		M B T - C A
>1.7 - <2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
< 1.7	
Organism	Reference
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm	
	High	Low	High	Low	High	Low	High	Low	High	Low	High	Low	High	Low
All
Bacteria	3079	389	52	12	10	5	5	3	5	0	1	0	22	1
	85.9%	10.9%	1.5%	0.3%	0.3%	0.1%	0.1%	0.1%	0.1%	0.0%	0.0%	0.0%	0.6%	0.0%
All Yeast	738	3	55	1	0	0	0	0	1	0	0	0	17	0
	90.6%	0.4%	6.7%	0.1%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	2.1%	0.0%
Anaerobes	482	34	5	1	0	0	1	0	3	0	0	0	4	0
	90.8%	6.4%	0.9%	0.2%	0.0%	0.0%	0.2%	0.0%	0.6%	0.0%	0.0%	0.0%	0.8%	0.0%
Gram-
Negatives	607	160	6	7	6	3	2	0	1	0	0	0	0	0
	76.6%	20.2%	0.8%	0.7%	0.8%	0.4%	0.3%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%
Gram-
Positives	1990	195	41	4	4	2	2	3	1	0	1	0	18	1
	88.0%	8.6%	1.8%	0.2%	0.2%	0.1%	0.1%	0.1%	0.0%	0.0%	0.0%	0.0%	80.0%	0.0%

--- Page 27 ---
Correct: Genus ID C o rrect: Genus ID
Correct: Species ID or Incorrect: Species ID or Incorrect: Genus ID No ID
Table: Organism Performance Group / Complex ID Group / Complex ID
MBT-CA M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A
> 2.0 >1.7 - <2.0 > 2.0 > 1.7 - < 2.0 > 2.0 > 1.7 - < 2.0 < 1.7
# R e ference R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e
Organism Isolates algorithm algorithm algorithm algorithm algorithm algorithm algorithm
(MM)
High Low High Low High Low High Low High Low High Low High Low
Acinetobacter 7(65) 11 2 0 0 1 0 0 0 0 0 0 0 0 0
haemolyticus 78.6% 14.3% 0.0% 0.0% 7.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Acinetobacter 34 0 0 0 1 0 0 0 0 0 0 0 0 0
9(25)
johnsonii 97.1% 0.0% 0.0% 0.0% 2.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
39 4 0 1 1 0 0 0 0 0 0 0 0 0
Acinetobacter junii 11(32)
86.7% 8.9% 0.0% 2.2% 2.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Actinomyces 3 0 0 0 0 0 0 0 0 0 0 0 0 0
3(33)
meyeri 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
26 0 0 0 0 0 0 0 1 0 0 0 0 0
Actinomyces neuii 10(29)
96.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.7% 0.0% 0.0% 0.0% 0.0% 0.0%
Actinomyces 18 0 0 0 0 0 0 0 0 0 0 0 0 1
8(56)
odontolyticus 94.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 5.3%
10 6 0 0 0 0 0 0 0 0 0 0 0 0
Actinomyces oris 5(30)
62.5% 37.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
51 0 0 0 0 0 0 0 0 0 0 0 0 0
Aerococcus urinae 0
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Aerococcus 10 0 12 0 0 0 0 0 0 0 0 0 0 10
2(8)
viridans 31.3% 0.0% 37.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 31.3%
Aeromonas 9 0 0 0 0 0 0 0 0 0 0 0 0 0
9(54)
salmonicida 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Anaerococcus 10 4 0 0 0 0 0 0 0 0 0 0 0 0
12(42)
vaginalis 71.4% 28.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
44 0 0 0 0 0 0 0 0 0 0 0 0 0
Bacteroides fragilis 1(1)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Bacteroides ovatus 14 18 0 0 0 0 0 0 0 0 0 0 0 0
12(12)
group 43.8% 56.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Bacteroides 29 0 0 0 0 0 0 0 1 0 0 0 0 0
thetaiotaomicron 0
96.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.3% 0.0% 0.0% 0.0% 0.0% 0.0%
group
Bacteroides 13 0 0 0 0 0 0 0 0 0 0 0 0 0
11(37)
uniformis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Bacteroides 50 0 0 0 0 0 0 0 0 0 0 0 0 0
14(21)
vulgatus group
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
0 19 0 0 0 0 0 0 0 0 0 0 0 0
Bordetella group[3] 8(69)
0.0% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
2 0 0 0 0 0 0 0 0 0 0 0 0 0
Bordetella hinzii 2(20)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Brevibacterium 11 0 0 0 0 0 0 0 0 0 0 0 0 0
7(20)
casei 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Brevundimonas 0 29 0 2 0 0 0 0 0 0 0 0 0 0
8(48)
diminuta group 0.0% 93.5% 0.0% 6.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
11 0 0 0 0 0 0 0 1 0 0 0 0 0
Campylobacter coli 9(21)
91.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 8.3% 0.0% 0.0% 0.0% 0.0% 0.0%
27

[Table 1 on page 27]
Table: Organism Performance		Correct: Genus ID
Correct: Species ID or
Group / Complex ID				C o rrect: Genus ID
Incorrect: Species ID or
Group / Complex ID				Incorrect: Genus ID				No ID	
		MBT-CA
> 2.0		M B T - C A
>1.7 - <2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
< 1.7	
Organism	#
Isolates
(MM)	R e ference
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm	
		High	Low	High	Low	High	Low	High	Low	High	Low	High	Low	High	Low
Acinetobacter
haemolyticus	7(65)	11	2	0	0	1	0	0	0	0	0	0	0	0	0
		78.6%	14.3%	0.0%	0.0%	7.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Acinetobacter
johnsonii	9(25)	34	0	0	0	1	0	0	0	0	0	0	0	0	0
		97.1%	0.0%	0.0%	0.0%	2.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Acinetobacter junii	11(32)	39	4	0	1	1	0	0	0	0	0	0	0	0	0
		86.7%	8.9%	0.0%	2.2%	2.2%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Actinomyces
meyeri	3(33)	3	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Actinomyces neuii	10(29)	26	0	0	0	0	0	0	0	1	0	0	0	0	0
		96.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	3.7%	0.0%	0.0%	0.0%	0.0%	0.0%
Actinomyces
odontolyticus	8(56)	18	0	0	0	0	0	0	0	0	0	0	0	0	1
		94.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	5.3%
Actinomyces oris	5(30)	10	6	0	0	0	0	0	0	0	0	0	0	0	0
		62.5%	37.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Aerococcus urinae	0	51	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Aerococcus
viridans	2(8)	10	0	12	0	0	0	0	0	0	0	0	0	0	10
		31.3%	0.0%	37.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	31.3%
Aeromonas
salmonicida	9(54)	9	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Anaerococcus
vaginalis	12(42)	10	4	0	0	0	0	0	0	0	0	0	0	0	0
		71.4%	28.6%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Bacteroides fragilis	1(1)	44	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Bacteroides ovatus
group	12(12)	14	18	0	0	0	0	0	0	0	0	0	0	0	0
		43.8%	56.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Bacteroides
thetaiotaomicron
group	0	29	0	0	0	0	0	0	0	1	0	0	0	0	0
		96.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	3.3%	0.0%	0.0%	0.0%	0.0%	0.0%
Bacteroides
uniformis	11(37)	13	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Bacteroides
vulgatus group	14(21)	50	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Bordetella group[3]	8(69)	0	19	0	0	0	0	0	0	0	0	0	0	0	0
		0.0%	100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Bordetella hinzii	2(20)	2	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Brevibacterium
casei	7(20)	11	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Brevundimonas
diminuta group	8(48)	0	29	0	2	0	0	0	0	0	0	0	0	0	0
		0.0%	93.5%	0.0%	6.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Campylobacter coli	9(21)	11	0	0	0	0	0	0	0	1	0	0	0	0	0
		91.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	8.3%	0.0%	0.0%	0.0%	0.0%	0.0%

--- Page 28 ---
Correct: Genus ID C o r r e ct: Genus ID
Correct: Species ID or I n correct: Species ID or Incorrect: Genus ID No ID
Table: Organism Performance Group / Complex ID Group / Complex ID
MBT-CA M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A
> 2.0 >1.7 - <2.0 > 2.0 > 1.7 - < 2.0 > 2.0 > 1.7 - < 2.0 < 1.7
# R eference R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e
Organism Isolates algorithm algorithm algorithm algorithm algorithm algorithm algorithm
(MM)
High Low High Low High Low High Low High Low High Low High Low
17 0 0 0 0 0 0 0 0 0 0 0 0 0
Campylobacter jejuni 2(20)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Campylobacter 1 0 0 0 0 0 0 0 0 0 0 0 0 0
1(7)
ureolyticus 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Capnocytophaga 2 2 0 0 0 0 0 0 0 0 0 0 0 0
4(40)
ochracea 50.0% 50.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Capnocytophaga 8 0 0 0 0 0 0 0 0 0 0 0 0 0
4(36)
sputigena 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Chryseobacterium 10 0 0 0 2 1 0 0 0 0 0 0 0 0
2(30)
gleum 76.9% 0.0% 0.0% 0.0% 15.4% 7.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Chryseobacterium 15 0 1 0 0 0 1 0 0 0 0 0 0 0
5(55)
indologenes 88.2% 0.0% 5.9% 0.0% 0.0% 0.0% 5.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
26 1 0 0 0 0 0 0 0 0 0 0 0 0
Clostridium difficile 3(9)
96.3% 3.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Clostridium 34 0 0 0 0 0 0 0 0 0 0 0 0 0
0
perfringens 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 5 35 0 0 0 0 0 0 0 0 0 0 0 0
3(5)
amycolatum 12.5% 87.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 24 0 1 0 0 0 0 0 0 0 0 0 3 1
13(23)
aurimucosum group 82.8% 0.0% 3.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 10.3% 3.4%
Corynebacterium 7 0 0 0 0 0 0 0 0 0 0 0 0 0
7(33)
bovis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 2 0 0 0 0 0 0 0 0 0 0 0 0 0
2(21)
diphtheriae 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 3 1 0 0 0 0 0 0 0 0 0 0 0 0
3(33)
glucuronolyticum 75.0% 25.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 30 0 0 0 0 0 0 0 0 0 0 0 0 0
6(41)
jeikeium 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 5 0 2 0 0 0 0 0 0 0 0 0 0 0
3(30)
kroppenstedtii 71.4% 0.0% 28.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 4 0 0 0 0 0 0 0 0 0 0 0 0 0
3(30)
macginleyi 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 1 1 1 0 0 0 0 0 0 0 0 0 0 0
2(30)
minutissimum 33.3% 33.3% 33.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 31 0 0 0 0 0 0 0 0 0 0 0 0 0
11(29)
propinquum 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 25 0 0 0 0 0 0 0 0 0 0 0 0 0
11(24)
pseudodiphtheriticum 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 1 0 0 0 0 0 0 0 0 0 0 0 0 0
1(15)
riegelii 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 43 4 1 0 0 0 0 0 0 0 0 0 0 0
2(2)
striatum group 89.6% 8.3% 2.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 9 0 2 0 0 0 0 0 0 0 0 0 0 0
5(26)
tuberculostearicum 81.8% 0.0% 18.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
28

[Table 1 on page 28]
Table: Organism Performance		Correct: Genus ID
Correct: Species ID or
Group / Complex ID				C o r r e ct: Genus ID
I n correct: Species ID or
Group / Complex ID				Incorrect: Genus ID				No ID	
		MBT-CA
> 2.0		M B T - C A
>1.7 - <2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
< 1.7	
Organism	#
Isolates
(MM)	R eference
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm	
		High	Low	High	Low	High	Low	High	Low	High	Low	High	Low	High	Low
Campylobacter jejuni	2(20)	17	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Campylobacter
ureolyticus	1(7)	1	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Capnocytophaga
ochracea	4(40)	2	2	0	0	0	0	0	0	0	0	0	0	0	0
		50.0%	50.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Capnocytophaga
sputigena	4(36)	8	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Chryseobacterium
gleum	2(30)	10	0	0	0	2	1	0	0	0	0	0	0	0	0
		76.9%	0.0%	0.0%	0.0%	15.4%	7.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Chryseobacterium
indologenes	5(55)	15	0	1	0	0	0	1	0	0	0	0	0	0	0
		88.2%	0.0%	5.9%	0.0%	0.0%	0.0%	5.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Clostridium difficile	3(9)	26	1	0	0	0	0	0	0	0	0	0	0	0	0
		96.3%	3.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Clostridium
perfringens	0	34	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
amycolatum	3(5)	5	35	0	0	0	0	0	0	0	0	0	0	0	0
		12.5%	87.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
aurimucosum group	13(23)	24	0	1	0	0	0	0	0	0	0	0	0	3	1
		82.8%	0.0%	3.4%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	10.3%	3.4%
Corynebacterium
bovis	7(33)	7	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
diphtheriae	2(21)	2	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
glucuronolyticum	3(33)	3	1	0	0	0	0	0	0	0	0	0	0	0	0
		75.0%	25.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
jeikeium	6(41)	30	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
kroppenstedtii	3(30)	5	0	2	0	0	0	0	0	0	0	0	0	0	0
		71.4%	0.0%	28.6%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
macginleyi	3(30)	4	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
minutissimum	2(30)	1	1	1	0	0	0	0	0	0	0	0	0	0	0
		33.3%	33.3%	33.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
propinquum	11(29)	31	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
pseudodiphtheriticum	11(24)	25	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
riegelii	1(15)	1	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
striatum group	2(2)	43	4	1	0	0	0	0	0	0	0	0	0	0	0
		89.6%	8.3%	2.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
tuberculostearicum	5(26)	9	0	2	0	0	0	0	0	0	0	0	0	0	0
		81.8%	0.0%	18.2%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

--- Page 29 ---
Correct: Genus ID C orrect: Genus ID
Correct: Species ID or I n c o r r e c t : S p e c i e s ID or Incorrect: Genus ID No ID
Table: Organism Performance Group / Complex ID Group / Complex ID
MBT-CA M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A
> 2.0 >1.7 - <2.0 > 2.0 > 1.7 - < 2.0 > 2.0 > 1.7 - < 2.0 < 1.7
# Reference R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e
Organism Isolates algorithm algorithm algorithm algorithm algorithm algorithm algorithm
(MM)
High Low High Low High Low High Low High Low High Low High Low
Corynebacterium 0 3 0 0 0 0 0 0 0 0 0 0 0 0
1(11)
ulcerans 0.0% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 10 0 0 0 0 0 0 0 0 0 0 0 0 0
3(23)
urealyticum 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Corynebacterium 1 0 0 0 0 0 0 0 0 0 0 0 0 0
1(15)
xerosis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cronobacter 37 0 0 0 0 0 0 0 0 0 0 0 0 0
15(43)
sakazakii group 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cupriavidus 10 0 0 0 0 0 0 0 0 0 0 0 0 0
2(36)
pauculus group 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Delftia 40 0 0 0 0 0 0 0 0 0 0 0 0 0
acidovorans 12(35)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
group
Dermacoccus 4 0 0 0 0 0 0 0 0 0 0 0 0 0
3(35)
nishinomiyaensis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
3 12 0 1 0 0 0 0 0 0 0 0 0 0
Edwardsiella tarda 4(45)
18.8% 75.0% 0.0% 6.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Elizabethkingia
20 0 0 0 0 0 0 0 0 0 0 0 0 0
meningoseptica 3(46)
group 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Enterobacter 12 4 0 0 0 0 1 0 0 0 0 0 0 0
5(53)
amnigenus 70.6% 23.5% 0.0% 0.0% 0.0% 0.0% 5.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
53 0 2 0 0 0 0 0 0 0 0 0 0 0
Enterococcus
0
avium group 96.4% 0.0% 3.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
48 0 1 0 0 0 0 0 0 0 0 0 0 0
Enterococcus
11(11)
casseliflavus 98.0% 0.0% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
60 0 0 0 0 0 0 0 0 0 0 0 0 0
Enterococcus
0
faecalis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Enterococcus 58 1 0 0 0 0 0 0 0 0 0 0 0 0
0
faecium 98.3% 1.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Enterococcus 30 0 0 0 0 0 0 0 0 0 0 0 0 0
0
gallinarum 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Enterococcus 17 0 0 0 0 0 0 1 0 0 0 0 0 0
5(10)
hirae 94.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 5.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
38 0 2 0 0 0 0 0 0 0 0 0 1 0
Finegoldia magna 0
92.7% 0.0% 4.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.4% 0.0%
Fusobacterium 0 3 0 0 0 0 0 0 0 0 0 0 0 0
3(23)
canifelinum 0.0% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Fusobacterium 3 0 0 0 0 0 0 0 0 0 0 0 0 0
3(29)
necrophorum 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Fusobacterium 4 0 2 1 0 0 0 0 0 0 0 0 0 0
3(32)
nucleatum 57.1% 0.0% 28.6% 14.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
29

[Table 1 on page 29]
Table: Organism Performance		Correct: Genus ID
Correct: Species ID or
Group / Complex ID				C orrect: Genus ID
I n c o r r e c t : S p e c i e s ID or
Group / Complex ID				Incorrect: Genus ID				No ID	
		MBT-CA
> 2.0		M B T - C A
>1.7 - <2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
< 1.7	
Organism	#
Isolates
(MM)	Reference
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm	
		High	Low	High	Low	High	Low	High	Low	High	Low	High	Low	High	Low
Corynebacterium
ulcerans	1(11)	0	3	0	0	0	0	0	0	0	0	0	0	0	0
		0.0%	100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
urealyticum	3(23)	10	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Corynebacterium
xerosis	1(15)	1	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Cronobacter
sakazakii group	15(43)	37	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Cupriavidus
pauculus group	2(36)	10	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Delftia
acidovorans
group	12(35)	40	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Dermacoccus
nishinomiyaensis	3(35)	4	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Edwardsiella tarda	4(45)	3	12	0	1	0	0	0	0	0	0	0	0	0	0
		18.8%	75.0%	0.0%	6.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Elizabethkingia
meningoseptica
group	3(46)	20	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Enterobacter
amnigenus	5(53)	12	4	0	0	0	0	1	0	0	0	0	0	0	0
		70.6%	23.5%	0.0%	0.0%	0.0%	0.0%	5.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Enterococcus
avium group	0	53	0	2	0	0	0	0	0	0	0	0	0	0	0
		96.4%	0.0%	3.6%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Enterococcus
casseliflavus	11(11)	48	0	1	0	0	0	0	0	0	0	0	0	0	0
		98.0%	0.0%	2.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Enterococcus
faecalis	0	60	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Enterococcus
faecium	0	58	1	0	0	0	0	0	0	0	0	0	0	0	0
		98.3%	1.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Enterococcus
gallinarum	0	30	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Enterococcus
hirae	5(10)	17	0	0	0	0	0	0	1	0	0	0	0	0	0
		94.4%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	5.6%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Finegoldia magna	0	38	0	2	0	0	0	0	0	0	0	0	0	1	0
		92.7%	0.0%	4.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	2.4%	0.0%
Fusobacterium
canifelinum	3(23)	0	3	0	0	0	0	0	0	0	0	0	0	0	0
		0.0%	100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Fusobacterium
necrophorum	3(29)	3	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Fusobacterium
nucleatum	3(32)	4	0	2	1	0	0	0	0	0	0	0	0	0	0
		57.1%	0.0%	28.6%	14.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

--- Page 30 ---
Correct: Genus ID C o r r e ct: Genus ID
Correct: Species ID or I ncorrect: Species ID or Incorrect: Genus ID No ID
Table: Organism Performance Group / Complex ID Group / Complex ID
MBT-CA M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A
> 2.0 >1.7 - <2.0 > 2.0 > 1.7 - < 2.0 > 2.0 > 1.7 - < 2.0 < 1.7
# R eference R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e
Organism Isolates algorithm algorithm algorithm algorithm algorithm algorithm algorithm
(MM)
High Low High Low High Low High Low High Low High Low High Low
5 0 0 0 0 0 0 0 0 0 0 0 0 0
Gardnerella vaginalis 4(40)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
8 0 0 0 0 0 0 0 0 0 0 0 0 0
Gemella haemolysans 3(30)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
3 0 0 0 0 0 0 0 0 0 0 0 0 0
Gemella sanguinis 3(30)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Granulicatella 17 0 0 0 0 0 0 0 0 0 0 0 0 0
2(25)
adiacens 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Haemophilus 21 9 1 0 0 0 0 0 0 0 0 0 0 0
7(28)
haemolyticus 67.7% 29.0% 3.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Haemophilus 66 8 0 0 0 0 0 0 0 0 0 0 0 0
0
influenzae 89.2% 10.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Haemophilus 16 0 0 0 0 0 0 0 0 0 0 0 0 0
parahaemolyticus 7(32)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
group
14 0 0 0 0 0 0 0 0 0 0 0 0 0
Kingella kingae 11(54)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
13 0 0 0 0 0 0 0 0 0 0 0 0 0
Kocuria kristinae 3(24)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Kytococcus 2 0 0 0 0 0 0 0 0 0 0 0 1 0
2(20)
sedentarius 66.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 33.3% 0.0%
16 0 0 0 0 0 0 0 0 0 0 0 0 0
Lactococcus garvieae 5(19)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
11 0 0 0 0 0 0 0 0 0 0 0 0 0
Lactococcus lactis 2(20)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Leuconostoc 0 7 0 0 0 0 0 0 0 0 0 0 0 0
3(30)
mesenteroides 0.0% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Macrococcus 10 0 0 0 0 0 0 0 0 0 0 0 0 0
4(37)
caseolyticus 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
52 0 0 1 0 0 0 0 0 0 0 0 0 0
Micrococcus luteus 0
98.1% 0.0% 0.0% 1.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Moraxella _ 24 0 0 0 0 0 0 0 0 0 0 0 0 0
sg_Moraxella 12(58)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
nonliquefaciens
Myroides 1 21 0 0 0 0 0 0 0 0 0 0 0 0
6(40)
odoratimimus 4.5% 95.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
7 0 0 0 0 0 0 0 0 0 0 0 0 0
Myroides odoratus 3(38)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
7 0 0 0 0 0 0 0 0 0 0 0 0 0
Oligella ureolytica 3(41)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
26 0 3 0 0 0 0 0 0 0 0 0 0 0
Oligella urethralis 11(54)
89.7% 0.0% 10.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
30

[Table 1 on page 30]
Table: Organism Performance		Correct: Genus ID
Correct: Species ID or
Group / Complex ID				C o r r e ct: Genus ID
I ncorrect: Species ID or
Group / Complex ID				Incorrect: Genus ID				No ID	
		MBT-CA
> 2.0		M B T - C A
>1.7 - <2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
< 1.7	
Organism	#
Isolates
(MM)	R eference
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm	
		High	Low	High	Low	High	Low	High	Low	High	Low	High	Low	High	Low
Gardnerella vaginalis	4(40)	5	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Gemella haemolysans	3(30)	8	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Gemella sanguinis	3(30)	3	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Granulicatella
adiacens	2(25)	17	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Haemophilus
haemolyticus	7(28)	21	9	1	0	0	0	0	0	0	0	0	0	0	0
		67.7%	29.0%	3.2%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Haemophilus
influenzae	0	66	8	0	0	0	0	0	0	0	0	0	0	0	0
		89.2%	10.8%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Haemophilus
parahaemolyticus
group	7(32)	16	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Kingella kingae	11(54)	14	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Kocuria kristinae	3(24)	13	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Kytococcus
sedentarius	2(20)	2	0	0	0	0	0	0	0	0	0	0	0	1	0
		66.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	33.3%	0.0%
Lactococcus garvieae	5(19)	16	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Lactococcus lactis	2(20)	11	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Leuconostoc
mesenteroides	3(30)	0	7	0	0	0	0	0	0	0	0	0	0	0	0
		0.0%	100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Macrococcus
caseolyticus	4(37)	10	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Micrococcus luteus	0	52	0	0	1	0	0	0	0	0	0	0	0	0	0
		98.1%	0.0%	0.0%	1.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Moraxella _
sg_Moraxella
nonliquefaciens	12(58)	24	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Myroides
odoratimimus	6(40)	1	21	0	0	0	0	0	0	0	0	0	0	0	0
		4.5%	95.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Myroides odoratus	3(38)	7	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Oligella ureolytica	3(41)	7	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Oligella urethralis	11(54)	26	0	3	0	0	0	0	0	0	0	0	0	0	0
		89.7%	0.0%	10.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

--- Page 31 ---
Correct: Genus ID C o rrect: Genus ID
Correct: Species ID or Incorrect: Species ID or Incorrect: Genus ID No ID
Table: Organism Performance Group / Complex ID Group / Complex ID
MBT-CA M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A
> 2.0 >1.7 - <2.0 > 2.0 > 1.7 - < 2.0 > 2.0 > 1.7 - < 2.0 < 1.7
# Reference R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e
Organism Isolates algorithm algorithm algorithm algorithm algorithm algorithm algorithm
(MM)
High Low High Low High Low High Low High Low High Low High Low
Parabacteroides 10 2 0 0 0 0 0 0 0 0 0 0 1 0
9(42)
distasonis 76.9% 15.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 7.7% 0.0%
Pediococcus 5 0 1 0 0 0 0 0 0 0 0 0 0 0
3(30)
pentosceus 83.3% 0.0% 16.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Peptoniphilus harei 31 0 0 0 0 0 1 0 0 0 0 0 0 0
0
group 96.9% 0.0% 0.0% 0.0% 0.0% 0.0% 3.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Peptostreptococcus 20 0 0 0 0 0 0 0 0 0 0 0 0 0
17(45)
anaerobius 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Plesiomonas 28 0 0 0 0 0 0 0 0 0 0 0 0 0
15(41)
shigelloides 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Porphyromonas 1 0 0 0 0 0 0 0 0 0 0 0 0 0
1(11)
gingivalis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
24 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella bivia 7(7)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
3 0 0 0 0 0 0 0 1 0 0 0 0 0
Prevotella buccae 3(35)
75.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 25.0% 0.0% 0.0% 0.0% 0.0% 0.0%
2 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella denticoa 2(23)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
2 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella intermedia 2(26)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Prevotella 2 0 0 0 0 0 0 0 0 0 0 0 0 0
2(20)
melaninogenica 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Propionibacterium 52 0 1 0 0 0 0 0 0 0 0 0 1 0
0
acnes 96.3% 0.0% 1.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.9% 0.0%
Pseudomonas 0 36 0 2 0 0 0 0 0 0 0 0 0 0
19(43)
oryzihabitans 0.0% 94.7% 0.0% 5.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
43 6 0 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas stutzeri 8(26)
87.8% 12.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
27 0 1 0 1 2 0 0 0 0 0 0 0 0
Rhizobium radiobacter 7(40)
87.1% 0.0% 3.2% 0.0% 3.2% 6.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
3 1 0 0 0 0 0 0 0 0 0 0 0 0
Rothia aeria 4(42)
75.0% 25.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
12 0 0 0 0 0 0 0 0 0 0 0 0 0
Rothia dentocariosa 9(18)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
31

[Table 1 on page 31]
Table: Organism Performance		Correct: Genus ID
Correct: Species ID or
Group / Complex ID				C o rrect: Genus ID
Incorrect: Species ID or
Group / Complex ID				Incorrect: Genus ID				No ID	
		MBT-CA
> 2.0		M B T - C A
>1.7 - <2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
< 1.7	
Organism	#
Isolates
(MM)	Reference
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm	
		High	Low	High	Low	High	Low	High	Low	High	Low	High	Low	High	Low
Parabacteroides
distasonis	9(42)	10	2	0	0	0	0	0	0	0	0	0	0	1	0
		76.9%	15.4%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	7.7%	0.0%
Pediococcus
pentosceus	3(30)	5	0	1	0	0	0	0	0	0	0	0	0	0	0
		83.3%	0.0%	16.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Peptoniphilus harei
group	0	31	0	0	0	0	0	1	0	0	0	0	0	0	0
		96.9%	0.0%	0.0%	0.0%	0.0%	0.0%	3.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Peptostreptococcus
anaerobius	17(45)	20	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Plesiomonas
shigelloides	15(41)	28	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Porphyromonas
gingivalis	1(11)	1	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Prevotella bivia	7(7)	24	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Prevotella buccae	3(35)	3	0	0	0	0	0	0	0	1	0	0	0	0	0
		75.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	25.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Prevotella denticoa	2(23)	2	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Prevotella intermedia	2(26)	2	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Prevotella
melaninogenica	2(20)	2	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Propionibacterium
acnes	0	52	0	1	0	0	0	0	0	0	0	0	0	1	0
		96.3%	0.0%	1.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.9%	0.0%
Pseudomonas
oryzihabitans	19(43)	0	36	0	2	0	0	0	0	0	0	0	0	0	0
		0.0%	94.7%	0.0%	5.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Pseudomonas stutzeri	8(26)	43	6	0	0	0	0	0	0	0	0	0	0	0	0
		87.8%	12.2%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Rhizobium radiobacter	7(40)	27	0	1	0	1	2	0	0	0	0	0	0	0	0
		87.1%	0.0%	3.2%	0.0%	3.2%	6.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Rothia aeria	4(42)	3	1	0	0	0	0	0	0	0	0	0	0	0	0
		75.0%	25.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Rothia dentocariosa	9(18)	12	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

--- Page 32 ---
Correct: Genus ID C o r r ect: Genus ID
Correct: Species ID or Incorrect: Species ID or Incorrect: Genus ID No ID
Table: Organism Performance Group / Complex ID Group / Complex ID
MBT-CA M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A
> 2.0 >1.7 - <2.0 > 2.0 > 1.7 - < 2.0 > 2.0 > 1.7 - < 2.0 < 1.7
# R eference R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e
Organism Isolates algorithm algorithm algorithm algorithm algorithm algorithm algorithm
(MM)
High Low High Low High Low High Low High Low High Low High Low
37 0 0 0 0 0 0 0 0 0 0 0 0 0
Rothia mucilaginosa 0
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
3 6 0 1 0 0 0 0 0 0 0 0 0 0
Serratia plymuthica 3(30)
30.0% 60.0% 0.0% 10.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
10 2 0 0 0 0 0 0 0 0 0 0 0 0
Serratia rubidaea 4(63)
83.3% 16.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
61 0 0 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus aureus 0
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 25 0 0 0 0 0 0 0 0 0 0 0 0 0
17(17)
auricularis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
49 1 1 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus capitis 0
96.1% 2.0% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
50 0 0 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus caprae 5(5)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 0 7 0 0 0 0 0 0 0 0 0 0 0 1
3(29)
carnosus 0.0% 87.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 12.5%
42 0 1 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus cohnii 5(10)
97.7% 0.0% 2.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 67 0 0 1 0 0 0 0 1 0 0 0 0 0
0
epidermidis 97.1% 0.0% 0.0% 1.4% 0.0% 0.0% 0.0% 0.0% 1.4% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 11 0 0 0 0 0 0 0 0 0 0 0 0 0
4(35)
equorum 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
4 0 0 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus felis 3(30)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 49 0 4 0 0 1 0 0 0 0 1 0 0 0
0
haemolyticus 89.1% 0.0% 7.3% 0.0% 0.0% 1.8% 0.0% 0.0% 0.0% 0.0% 1.8% 0.0% 0.0% 0.0%
Staphylococcus 57 0 0 1 0 0 0 0 0 0 0 0 1 0
0
hominis 96.6% 0.0% 0.0% 1.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.7% 0.0%
Staphylococcus 57 0 0 0 0 0 0 0 0 0 0 0 0 0
0
lugdunensis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 24 0 2 0 0 0 0 0 0 0 0 0 0 0
5(10)
pasteuri 92.3% 0.0% 7.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 56 0 1 0 0 0 0 0 0 0 0 0 0 0
0
pettenkoferi 98.2% 0.0% 1.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 0 59 0 0 0 0 0 0 0 0 0 0 0 0
0
pseudintermedius 0.0% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 1 0 0 0 0 0 0 0 0 0 0 0 0 0
1(10)
saccharolyticus 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0. 0%
32

[Table 1 on page 32]
Table: Organism Performance		Correct: Genus ID
Correct: Species ID or
Group / Complex ID				C o r r ect: Genus ID
Incorrect: Species ID or
Group / Complex ID				Incorrect: Genus ID				No ID	
		MBT-CA
> 2.0		M B T - C A
>1.7 - <2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
< 1.7	
Organism	#
Isolates
(MM)	R eference
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm	
		High	Low	High	Low	High	Low	High	Low	High	Low	High	Low	High	Low
Rothia mucilaginosa	0	37	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Serratia plymuthica	3(30)	3	6	0	1	0	0	0	0	0	0	0	0	0	0
		30.0%	60.0%	0.0%	10.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Serratia rubidaea	4(63)	10	2	0	0	0	0	0	0	0	0	0	0	0	0
		83.3%	16.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus aureus	0	61	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
auricularis	17(17)	25	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus capitis	0	49	1	1	0	0	0	0	0	0	0	0	0	0	0
		96.1%	2.0%	2.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus caprae	5(5)	50	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
carnosus	3(29)	0	7	0	0	0	0	0	0	0	0	0	0	0	1
		0.0%	87.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	12.5%
Staphylococcus cohnii	5(10)	42	0	1	0	0	0	0	0	0	0	0	0	0	0
		97.7%	0.0%	2.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
epidermidis	0	67	0	0	1	0	0	0	0	1	0	0	0	0	0
		97.1%	0.0%	0.0%	1.4%	0.0%	0.0%	0.0%	0.0%	1.4%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
equorum	4(35)	11	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus felis	3(30)	4	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
haemolyticus	0	49	0	4	0	0	1	0	0	0	0	1	0	0	0
		89.1%	0.0%	7.3%	0.0%	0.0%	1.8%	0.0%	0.0%	0.0%	0.0%	1.8%	0.0%	0.0%	0.0%
Staphylococcus
hominis	0	57	0	0	1	0	0	0	0	0	0	0	0	1	0
		96.6%	0.0%	0.0%	1.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.7%	0.0%
Staphylococcus
lugdunensis	0	57	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
pasteuri	5(10)	24	0	2	0	0	0	0	0	0	0	0	0	0	0
		92.3%	0.0%	7.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
pettenkoferi	0	56	0	1	0	0	0	0	0	0	0	0	0	0	0
		98.2%	0.0%	1.8%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
pseudintermedius	0	0	59	0	0	0	0	0	0	0	0	0	0	0	0
		0.0%	100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
saccharolyticus	1(10)	1	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0. 0%

--- Page 33 ---
Correct: Genus ID C o r r e ct: Genus ID
Correct: Species ID or I ncorrect: Species ID or Incorrect: Genus ID No ID
Table: Organism Performance Group / Complex ID Group / Complex ID
MBT-CA M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A
> 2.0 >1.7 - <2.0 > 2.0 > 1.7 - < 2.0 > 2.0 > 1.7 - < 2.0 < 1.7
# Reference R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e
Organism Isolates algorithm algorithm algorithm algorithm algorithm algorithm algorithm
(MM)
High Low High Low High Low High Low High Low High Low High Low
Staphylococcus 0 59 0 0 0 0 0 0 0 0 0 0 0 0
0
saprophyticus 0.0% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 29 0 0 0 0 0 0 0 0 0 0 0 0 0
0
schleiferi 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 46 0 1 0 0 0 0 0 0 0 0 0 2 0
0
simulans 0.0% 100.0% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 4.1% 0.0%
Staphylococcus 0 10 0 0 0 0 0 0 0 0 0 0 0 0
3(30)
vitulinus 0.0% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Staphylococcus 55 0 2 0 0 0 0 0 0 0 0 0 0 0
0
warneri 96.5% 0.0% 3.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 63 0 0 0 0 0 0 0 0 0 0 0 0 0
0
agalactiae 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 68 0 0 0 0 0 0 0 0 0 0 0 0 0
0
anginosus 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 40 0 0 0 0 0 0 0 0 0 0 0 0 0
2(8)
constellatus 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 58 0 0 0 1 0 1 0 0 0 0 0 0 0
0
dysgalactiae 96.7% 0.0% 0.0% 0.0% 1.7% 0.0% 1.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 34 0 1 0 0 0 0 0 0 0 0 0 0 0
1(4)
gallolyticus 97.1% 0.0% 2.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 27 0 0 0 0 0 1 2 0 0 0 0 0 0
6(16)
gordonii 90.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.3% 6.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 42 0 0 0 0 0 0 0 0 0 0 0 0 0
6(14)
intermedius 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 18 0 0 0 0 0 0 0 0 0 0 0 0 0
2(22)
lutetiensis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 61 6 3 1 2 0 0 0 0 0 0 0 0 0
1 isolate S.
mitis / oralis
mitis (9) 83.6% 8.2% 4.1% 1.4% 2.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
group
Streptococcus 25 0 0 0 0 0 0 0 0 0 0 0 0 0
2(16)
mutans 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 30 0 0 0 1 1 0 0 0 0 0 0 0 0
0
pneumoniae 93.8% 0.0% 0.0% 0.0% 3.1% 3.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 56 0 0 0 0 0 0 0 0 0 0 0 0 0
0
pyogenes 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Streptococcus 59 0 2 0 0 0 0 0 0 0 0 0 0 0
3(28)
salivarius 96.7% 0.0% 3.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sutterella 2 0 0 0 0 0 0 0 0 0 0 0 0 0
2(26)
wadsworthensis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
20 0 0 0 0 0 0 0 0 0 0 0 0 0
Vibrio
2(16)
parahaemolyticus 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
13 0 0 0 0 0 0 0 0 0 0 0 0 0
Vibrio vulnificus 3(27)
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
33

[Table 1 on page 33]
Table: Organism Performance		Correct: Genus ID
Correct: Species ID or
Group / Complex ID				C o r r e ct: Genus ID
I ncorrect: Species ID or
Group / Complex ID				Incorrect: Genus ID				No ID	
		MBT-CA
> 2.0		M B T - C A
>1.7 - <2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
< 1.7	
Organism	#
Isolates
(MM)	Reference
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm	
		High	Low	High	Low	High	Low	High	Low	High	Low	High	Low	High	Low
Staphylococcus
saprophyticus	0	0	59	0	0	0	0	0	0	0	0	0	0	0	0
		0.0%	100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
schleiferi	0	29	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
simulans	0	46	0	1	0	0	0	0	0	0	0	0	0	2	0
		0.0%	100.0%	2.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	4.1%	0.0%
Staphylococcus
vitulinus	3(30)	0	10	0	0	0	0	0	0	0	0	0	0	0	0
		0.0%	100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Staphylococcus
warneri	0	55	0	2	0	0	0	0	0	0	0	0	0	0	0
		96.5%	0.0%	3.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
agalactiae	0	63	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
anginosus	0	68	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
constellatus	2(8)	40	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
dysgalactiae	0	58	0	0	0	1	0	1	0	0	0	0	0	0	0
		96.7%	0.0%	0.0%	0.0%	1.7%	0.0%	1.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
gallolyticus	1(4)	34	0	1	0	0	0	0	0	0	0	0	0	0	0
		97.1%	0.0%	2.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
gordonii	6(16)	27	0	0	0	0	0	1	2	0	0	0	0	0	0
		90.0%	0.0%	0.0%	0.0%	0.0%	0.0%	3.3%	6.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
intermedius	6(14)	42	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
lutetiensis	2(22)	18	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
mitis / oralis
group	1 isolate S.
mitis (9)	61	6	3	1	2	0	0	0	0	0	0	0	0	0
		83.6%	8.2%	4.1%	1.4%	2.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
mutans	2(16)	25	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
pneumoniae	0	30	0	0	0	1	1	0	0	0	0	0	0	0	0
		93.8%	0.0%	0.0%	0.0%	3.1%	3.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
pyogenes	0	56	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Streptococcus
salivarius	3(28)	59	0	2	0	0	0	0	0	0	0	0	0	0	0
		96.7%	0.0%	3.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Sutterella
wadsworthensis	2(26)	2	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Vibrio
parahaemolyticus	2(16)	20	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Vibrio vulnificus	3(27)	13	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

--- Page 34 ---
Correct: Genus ID C o r rect: Genus ID
Correct: Species ID or Incorrect: Species ID or Incorrect: Genus ID No ID
Table: Organism Performance Group / Complex ID Group / Complex ID
MBT-CA M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A
> 2.0 >1.7 - <2.0 > 2.0 > 1.7 - < 2.0 > 2.0 > 1.7 - < 2.0 < 1.7
# R eference R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e
Yeast Isolates algorithm algorithm algorithm algorithm algorithm algorithm algorithm
(MM)
High Low High Low High Low High Low High Low High Low High Low
Candida 0 49 0 1 0 0 0 0 0 0 0 0 0 0 0
albicans 98.0% 0.0% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Candida 8(36) 7 0 0 0 0 0 0 0 0 0 0 0 1 0
boidinii 87.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 12.5% 0.0%
Candida 5(13) 34 0 5 0 0 0 0 0 1 0 0 0 2 0
dubliniensis 81.00% 0.0% 11.9% 0.0% 0.0% 0.0% 0.0% 0.0% 2.4% 0.0% 0.0% 0.0% 4.8% 0.0%
Candida 4(42) 5 0 0 0 0 0 0 0 0 0 0 0 0 0
duobushaemulonii 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
11(28) 10 0 1 0 0 0 0 0 0 0 0 0 0 0
Candida famata
90.9% 0.0% 9.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
1(1) 43 0 0 0 0 0 0 0 0 0 0 0 0 0
Candida glabrata
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Candida 18(29) 30 0 1 0 0 0 0 0 0 0 0 0 5 0
guilliermondii 83.3% 0.0% 2.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 13.9% 0.0%
Candida 7(35) 9 0 0 0 0 0 0 0 0 0 0 0 0 0
haemulonis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Candida 3(29) 4 3 0 1 0 0 0 0 0 0 0 0 0 0
inconspicua 50.0% 37.5% 0.0% 12.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
13(13) 38 0 3 0 0 0 0 0 0 0 0 0 0 0
Candida kefyr
92.7% 0.0% 7.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
4(8) 67 0 0 0 0 0 0 0 0 0 0 0 0 0
Candida krusei
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
10(40) 12 0 1 0 0 0 0 0 0 0 0 0 2 0
Candida lambica
80.0% 0.0% 6.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 13.3% 0.0%
11(11) 22 0 0 0 0 0 0 0 0 0 0 0 0 0
Candida lipolytica
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Candida 6(6) 50 0 2 0 0 0 0 0 0 0 0 0 0 0
lusitaniae 96.2% 0.0% 3.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Candida 3(22) 2 0 3 0 0 0 0 0 0 0 0 0 1 0
metapsilosis 33.3% 0.0% 50.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 16.7% 0.0%
Candida 13(23) 19 0 0 0 0 0 0 0 0 0 0 0 0 0
norvegensis 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Candida 9(34) 19 0 1 0 0 0 0 0 0 0 0 0 0 0
orthopsilosis 95.0% 0.0% 5.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Candida 0 58 0 5 0 0 0 0 0 0 0 0 0 0 0
parapsilosis 92.1% 0.0% 7.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
34

[Table 1 on page 34]
Table: Organism Performance		Correct: Genus ID
Correct: Species ID or
Group / Complex ID				C o r rect: Genus ID
Incorrect: Species ID or
Group / Complex ID				Incorrect: Genus ID				No ID	
		MBT-CA
> 2.0		M B T - C A
>1.7 - <2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
< 1.7	
Yeast	#
Isolates
(MM)	R eference
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm	
		High	Low	High	Low	High	Low	High	Low	High	Low	High	Low	High	Low
Candida
albicans	0	49	0	1	0	0	0	0	0	0	0	0	0	0	0
		98.0%	0.0%	2.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida
boidinii	8(36)	7	0	0	0	0	0	0	0	0	0	0	0	1	0
		87.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	12.5%	0.0%
Candida
dubliniensis	5(13)	34	0	5	0	0	0	0	0	1	0	0	0	2	0
		81.00%	0.0%	11.9%	0.0%	0.0%	0.0%	0.0%	0.0%	2.4%	0.0%	0.0%	0.0%	4.8%	0.0%
Candida
duobushaemulonii	4(42)	5	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida famata	11(28)	10	0	1	0	0	0	0	0	0	0	0	0	0	0
		90.9%	0.0%	9.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida glabrata	1(1)	43	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida
guilliermondii	18(29)	30	0	1	0	0	0	0	0	0	0	0	0	5	0
		83.3%	0.0%	2.8%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	13.9%	0.0%
Candida
haemulonis	7(35)	9	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida
inconspicua	3(29)	4	3	0	1	0	0	0	0	0	0	0	0	0	0
		50.0%	37.5%	0.0%	12.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida kefyr	13(13)	38	0	3	0	0	0	0	0	0	0	0	0	0	0
		92.7%	0.0%	7.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida krusei	4(8)	67	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida lambica	10(40)	12	0	1	0	0	0	0	0	0	0	0	0	2	0
		80.0%	0.0%	6.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	13.3%	0.0%
Candida lipolytica	11(11)	22	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida
lusitaniae	6(6)	50	0	2	0	0	0	0	0	0	0	0	0	0	0
		96.2%	0.0%	3.8%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida
metapsilosis	3(22)	2	0	3	0	0	0	0	0	0	0	0	0	1	0
		33.3%	0.0%	50.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	16.7%	0.0%
Candida
norvegensis	13(23)	19	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida
orthopsilosis	9(34)	19	0	1	0	0	0	0	0	0	0	0	0	0	0
		95.0%	0.0%	5.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida
parapsilosis	0	58	0	5	0	0	0	0	0	0	0	0	0	0	0
		92.1%	0.0%	7.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

--- Page 35 ---
Correct: Genus ID C o r r e c t: Genus ID
Correct: Species ID or I ncorrect: Species ID or Incorrect: Genus ID No ID
Table: Organism Performance Group / Complex ID Group / Complex ID
MBT-CA M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A M B T - C A
> 2.0 >1.7 - <2.0 > 2.0 > 1.7 - < 2.0 > 2.0 > 1.7 - < 2.0 < 1.7
# Reference R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e R e f e r e n c e
Yeast Isolates (MM) algorithm algorithm algorithm algorithm algorithm algorithm algorithm
High Low High Low High Low High Low High Low High Low High Low
Candida 3(35) 3 0 0 0 0 0 0 0 0 0 0 0 0 0
pararugosa
100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Candida 9(24) 12 0 0 0 0 0 0 0 0 0 0 0 0 0
pelliculosa 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Candida 11(24) 56 0 2 0 0 0 0 0 0 0 0 0 2 0
tropicalis 93.3% 0.0% 3.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.3% 0.0%
Candida 9(35) 8 0 1 0 0 0 0 0 0 0 0 0 0 0
valida 88.9% 0.0% 11.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cryptococcus 11(22) 14 0 0 0 0 0 0 0 0 0 0 0 0 0
gattii 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cryptococcus 4(10) 38 0 11 0 0 0 0 0 0 0 0 0 2 0
neoformans
var grubii 74.5% 0.0% 21.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.9% 0.0%
Cryptococcus 4(34)
8 0 2 0 0 0 0 0 0 0 0 0 0 0
neoformans var
neoformans 80.0% 0.0% 20.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Geotrichum 3(33) 7 0 1 0 0 0 0 0 0 0 0 0 0 0
candidum
87.5% 0.0% 12.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Geotrichum 10(20) 20 0 1 0 0 0 0 0 0 0 0 0 1 0
capitatum 90.9% 0.0% 4.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 4.5% 0.0%
Kloeckera 9(27) 9 0 0 0 0 0 0 0 0 0 0 0 0 0
apiculata 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Pichia 1 0 ( 2 7) 6 0 4 0 0 0 0 0 0 0 0 0 0 0
ohmeri 60.0% 0.0% 40.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Saccharomyces 0 53 0 10 0 0 0 0 0 0 0 0 0 1 0
cerevisiae
82.8% 0.0% 15.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.6% 0.0%
Trichosporon 6(18) 26 0 0 0 0 0 0 0 0 0 0 0 0 0
asahii 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
b. Clinical specificity: See clinical sensitivity results
c. Other clinical supportive data:
Organism identification (direct or extracted) is reported with high confidence if the
log(score) is ≥ 2.00. If a direct transfer organism identification log (score) is <2.00;
the user is instructed to follow and extraction procedure (eDT or EXT). Performance
by testing method is summarized below.
35

[Table 1 on page 35]
Table: Organism Performance		Correct: Genus ID
Correct: Species ID or
Group / Complex ID				C o r r e c t: Genus ID
I ncorrect: Species ID or
Group / Complex ID				Incorrect: Genus ID				No ID	
		MBT-CA
> 2.0		M B T - C A
>1.7 - <2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
> 2.0		M B T - C A
> 1.7 - < 2.0		M B T - C A
< 1.7	
Yeast	#
Isolates (MM)	Reference
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm		R e f e r e n c e
algorithm	
		High	Low	High	Low	High	Low	High	Low	High	Low	High	Low	High	Low
Candida
pararugosa	3(35)	3	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida
pelliculosa	9(24)	12	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Candida
tropicalis	11(24)	56	0	2	0	0	0	0	0	0	0	0	0	2	0
		93.3%	0.0%	3.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	3.3%	0.0%
Candida
valida	9(35)	8	0	1	0	0	0	0	0	0	0	0	0	0	0
		88.9%	0.0%	11.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Cryptococcus
gattii	11(22)	14	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Cryptococcus
neoformans
var grubii	4(10)	38	0	11	0	0	0	0	0	0	0	0	0	2	0
		74.5%	0.0%	21.6%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	3.9%	0.0%
Cryptococcus
neoformans var
neoformans	4(34)	8	0	2	0	0	0	0	0	0	0	0	0	0	0
		80.0%	0.0%	20.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Geotrichum
candidum	3(33)	7	0	1	0	0	0	0	0	0	0	0	0	0	0
		87.5%	0.0%	12.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Geotrichum
capitatum	10(20)	20	0	1	0	0	0	0	0	0	0	0	0	1	0
		90.9%	0.0%	4.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	4.5%	0.0%
Kloeckera
apiculata	9(27)	9	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Pichia
ohmeri	1 0 ( 2 7)	6	0	4	0	0	0	0	0	0	0	0	0	0	0
		60.0%	0.0%	40.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Saccharomyces
cerevisiae	0	53	0	10	0	0	0	0	0	0	0	0	0	1	0
		82.8%	0.0%	15.6%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.6%	0.0%
Trichosporon
asahii	6(18)	26	0	0	0	0	0	0	0	0	0	0	0	0	0
		100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

--- Page 36 ---
Table: Overall identificagion results by testing method
(includes isolates and replicate testing) for bacteria and yeasts.
METHOD SCORE BACTERIA YEAST
DT >2.0 5824 (86.8%) 731 (48.9%)
Alone >1.7 - <2.0 547 (8.2%) 224 (15.0%)
<1.7 337 (5.0%) 539 (36.1%)
Total 6708 1494
DT with >2.0 6309 (94.7%) 1193 (81.6%)
eDT >1.7 - <2.0 245 (3.7%) 168 (11.5%)
<1.7 105 (1.6%) 101 (6.9%)
Total 6659 1462
DT with >2.0 6491 (97.0%) 1220 (83.4%)
EXT >1.7 - <2.0 160 (2.4%) 156 (10.7%)
<1.7 39 (0.6%) 87 (5.9%)
Total 6690 1463
4. Clinical cut-off:
See Assay cut-off
5. Expected values/Reference range:
See Assay cut-off
N. Instrument Name: MBT CA System
O. System Descriptions: Also see K130831
1. Modes of Operation:
Does the applicant’s device contain the ability to transmit data to a computer, webserver,
or mobile device?
Yes ____X____ or No ________
Does the applicant’s device transmit data to a computer, webserver, or mobile device
using wireless transmission?
Yes ________ or No __X______
36

[Table 1 on page 36]
METHOD		SCORE	BACTERIA	YEAST	
DT
Alone		>2.0	5824 (86.8%)	731 (48.9%)	
		>1.7 - <2.0	547 (8.2%)	224 (15.0%)	
		<1.7	337 (5.0%)	539 (36.1%)	
		Total	6708	1494	
					
DT with
eDT		>2.0	6309 (94.7%)	1193 (81.6%)	
		>1.7 - <2.0	245 (3.7%)	168 (11.5%)	
		<1.7	105 (1.6%)	101 (6.9%)	
		Total	6659	1462	
					
DT with
EXT		>2.0	6491 (97.0%)	1220 (83.4%)	
		>1.7 - <2.0	160 (2.4%)	156 (10.7%)	
		<1.7	39 (0.6%)	87 (5.9%)	
		Total	6690	1463	

--- Page 37 ---
2. Software:
FDA has reviewed applicant’s Hazard Analysis and software development processes for
this line of product types:
Yes _____X___ or No ________
3. Specimen Identification:
The user manually enters the specimen identification information into the MALDI
Biotyper CA System. The user first defines active sample positions (see section 4.2.1 of
User Manual) and US IVD BTS control positions (see section 4.2.2 of User Manual).
The defined sample positions are required to have a user entered and valid sample
identifier in the Id column along with an optional description. All inoculated positions
must contain a valid ID before the run can proceed. After all sample positions have been
input, at least two US IVD BTS control positions must be defined. It is recommended
that the cross-joint positions on the target are used as quality control positions.
Alternatively, the user can use an optional Honeywell (Hyperion 1300g) Barcode Reader
USB cable is connected to the MALDI Biotyper CA System computer. The barcode
reader scans the unique ten-digit target ID which appears in the Target ID box on the
target plate. After the target ID has been entered, the a new Run page opens and the ten-
digit target ID appears as the Plate Id and is appended to the Run name. Sample
identifications are entered into the computer corresponding to the target plate position for
that run.
4. Specimen Sampling and Handling:
After incubation of bacteria on recommended isolation media for 18–24 h at (37°C
±2°C), colonies are stable for up to 12 h when held at room temperature. See Section
M.1.i. above.
Using a sterile colony transfer device, smear isolated colonies of bacteria as a thin film
directly onto a sample position on a cleaned target. Inoculating an appropriate amount of
the test organism onto the target is important. Excessive or insufficient amounts of
inoculum may impact organism identification. The User Manual visually illustrates
suitable and unsuitable inoculum amounts of organism on target.
Each of the sample positions and US IVD BTS control positions are overlayed with 1 μL
US IVD HCCA portioned solution. Use a new pipette tip to add matrix to each inoculated
sample position. Dry the inoculated plate at room temperature. The inoculated MALDI
target plate is now ready for use. For stability see Sections M.1.j and M.1.k above.
If the MALDI BIOTYPER CA System identification of the test organism does not result
in a bacterial identification with a log(score) value of ≥ 2.0, repeat testing using the
extraction procedure in Section 3.6 of the User Manual. Briefly, the extraction of a
sample from an isolated colony consists of multiple washing cycles of ethanol and water
37

--- Page 38 ---
followed by addition of formic acid and acetonitrile followed by a centrifugation step.
After centrifugation, a sample of the supernatant is applied to the target plate, dried and
loaded into the MALDI Biotyper CA System for analysis.
5. Calibration: See K130831
6. Quality Control: See Section M.1.c above.
P. Proposed Labeling:
The labeling is sufficient and satisfies the requirements of 21 CFR Part 809.10, 21 CFR
801.109, and special controls of regulation 21 CFR 866. 3361.
Q. Conclusion:
The submitted information in this premarket notification is complete and supports a
substantial equivalence decision.
38